Highly	O
polarized	O
HLA	B-protein
class	I-protein
II	I-protein
antigen	I-protein
processing	O
and	O
presentation	O
by	O
human	B-cell_type
intestinal	I-cell_type
epithelial	I-cell_type
cells	I-cell_type
.	O

The	O
high	O
concentration	O
of	O
foreign	B-protein
antigen	I-protein
in	O
the	O
lumen	B-cell_type
of	O
the	O
gastrointestinal	O
tract	O
is	O
separated	O
from	O
the	O
underlying	O
lymphocytes	B-cell_type
by	O
a	O
single	O
cell	O
layer	O
of	O
polarized	O
epithelium	O
.	O

Intestinal	B-cell_type
epithelial	I-cell_type
cells	I-cell_type
can	O
express	O
HLA	B-protein
class	I-protein
II	I-protein
antigens	I-protein
and	O
may	O
function	O
as	O
antigen-presenting	B-cell_type
cells	I-cell_type
to	I-cell_type
CD4	I-cell_type
(	I-cell_type
+	I-cell_type
)	I-cell_type
T	I-cell_type
cells	I-cell_type
within	O
the	O
intestinal	O
mucosa	O
.	O

Using	O
tetanus	B-cell_type
toxoid	I-cell_type
specific	I-cell_type
and	I-cell_type
HLA-DR-restricted	I-cell_type
T	I-cell_type
lymphocytes	I-cell_type
,	O
we	O
show	O
that	O
polarized	B-cell_type
intestinal	I-cell_type
epithelial	I-cell_type
cells	I-cell_type
directed	O
to	O
express	O
HLA-DR	B-protein
molecules	I-protein
are	O
able	O
to	O
initiate	O
class	O
II	O
processing	O
only	O
after	O
internalization	O
of	O
antigen	O
from	O
their	O
apical	O
surface	O
.	O

Coexpression	O
of	O
the	O
class	B-protein
II	I-protein
transactivator	I-protein
CIITA	I-protein
in	O
these	O
cells	O
,	O
which	O
stimulates	O
highly	O
efficient	O
class	O
II	O
processing	O
without	O
the	O
characteristic	O
decline	O
in	O
barrier	O
function	O
seen	O
in	O
polarized	O
monolayers	O
treated	O
with	O
the	O
proinflammatory	B-protein
cytokine	I-protein
gamma-IFN	I-protein
,	O
facilitates	O
antigen	O
processing	O
from	O
the	O
basolateral	O
surface	O
.	O

In	O
both	O
cases	O
,	O
peptide	O
presentation	O
to	O
T	B-cell_type
cells	I-cell_type
via	O
class	B-protein
II	I-protein
molecules	I-protein
was	O
restricted	O
to	O
the	O
basolateral	O
surface	O
.	O

These	O
data	O
indicate	O
a	O
highly	O
polarized	O
functional	O
architecture	O
for	O
antigen	O
processing	O
and	O
presentation	O
by	O
intestinal	B-cell_type
epithelial	I-cell_type
cells	I-cell_type
,	O
and	O
suggest	O
that	O
the	O
functional	O
outcome	O
of	O
antigen	O
processing	O
by	O
the	O
intestinal	O
epithelium	O
is	O
both	O
dependent	O
on	O
the	O
cellular	O
surface	O
at	O
which	O
the	O
foreign	O
antigen	O
is	O
internalized	O
and	O
by	O
the	O
underlying	O
degree	O
of	O
mucosal	O
inflammation	O

Highly	NULL
Polarized	NULL
HLA	NULL
Class	NULL
II	NULL
Antigen	NULL
Processing	NULL
and	NULL
Presentation	NULL
by	NULL
Human	NULL
Intestinal	NULL
Epithelial	NULL
Cells	NULL
Robert	NULL
M.	NULL
Hershberg	NULL
,	NULL
**	NULL
Diane	NULL
H.	NULL
Cho	NULL
,	NULL
*	NULL
Adel	NULL
Youakim	NULL
,	NULL
'	NULL
M.	NULL
Brigid	NULL
Bradley	NULL
,	NULL
``	NULL
Janet	NULL
S.	NULL
Lee	NULL
,	NULL
``	NULL
Paul	NULL
E.	NULL
Framson	NULL
,	NULL
*	NULL
and	NULL
Gerald	NULL
T.	NULL
Nepom*	NULL
$	NULL
*Virginia	NULL
Mason	NULL
Research	NULL
Center	NULL
,	NULL
Seattle	NULL
,	NULL
Washington	NULL
98101	NULL
;	NULL
*Division	NULL
of	NULL
Medical	NULL
Genetics	NULL
,	NULL
and	NULL
§Department	NULL
of	NULL
Immunology	NULL
,	NULL
University	NULL
of	NULL
Washington	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Seattle	NULL
,	NULL
Washington	NULL
98195	NULL
;	NULL
\Immunex	NULL
Corporation	NULL
,	NULL
Seattle	NULL
,	NULL
Washington	NULL
98101	NULL
;	NULL
and	NULL
``	NULL
Immunology	NULL
Program	NULL
,	NULL
Memorial	NULL
Sloan	NULL
Kettering	NULL
Cancer	NULL
Center	NULL
,	NULL
New	NULL
York	NULL
10021	NULL
Abstract	NULL
The	NULL
high	NULL
concentration	NULL
of	NULL
foreign	NULL
antigen	NULL
in	NULL
the	NULL
lumen	NULL
of	NULL
the	NULL
gastrointestinal	NULL
tract	NULL
is	NULL
separated	NULL
from	NULL
the	NULL
underlying	NULL
lymphocytes	NULL
by	NULL
a	NULL
single	NULL
cell	NULL
layer	NULL
of	NULL
polarized	NULL
epithelium	NULL
.	NULL

Intestinal	NULL
epithelial	NULL
cells	NULL
can	NULL
express	NULL
HLA	NULL
class	NULL
II	NULL
antigens	NULL
and	NULL
may	NULL
function	NULL
as	NULL
antigen-presenting	NULL
cells	NULL
to	NULL
CD4*	NULL
T	NULL
cells	NULL
within	NULL
the	NULL
intestinal	NULL
mucosa	NULL
.	NULL

Using	NULL
tetanus	NULL
toxoid	NULL
specific	NULL
and	NULL
HLA-DR-restricted	NULL
T	NULL
lymphocytes	NULL
,	NULL
we	NULL
show	NULL
that	NULL
polarized	NULL
intestinal	NULL
epithelial	NULL
cells	NULL
directed	NULL
to	NULL
express	NULL
HLA-DR	NULL
molecules	NULL
are	NULL
able	NULL
to	NULL
initiate	NULL
class	NULL
II	NULL
processing	NULL
only	NULL
after	NULL
internalization	NULL
of	NULL
antigen	NULL
from	NULL
their	NULL
apical	NULL
surface	NULL
.	NULL

Co-expression	NULL
of	NULL
the	NULL
class	NULL
II	NULL
transactivator	NULL
CIITA	NULL
in	NULL
these	NULL
cells	NULL
,	NULL
which	NULL
stimulates	NULL
highly	NULL
efficient	NULL
class	NULL
II	NULL
processing	NULL
without	NULL
the	NULL
characteristic	NULL
decline	NULL
in	NULL
barrier	NULL
function	NULL
seen	NULL
in	NULL
polarized	NULL
monolayers	NULL
treated	NULL
with	NULL
the	NULL
proinflammatory	NULL
cytokine	NULL
y-IFN	NULL
,	NULL
facilitates	NULL
antigen	NULL
processing	NULL
from	NULL
the	NULL
basolateral	NULL
surface	NULL
.	NULL

In	NULL
both	NULL
cases	NULL
,	NULL
peptide	NULL
presentation	NULL
to	NULL
T	NULL
cells	NULL
via	NULL
class	NULL
II	NULL
molecules	NULL
was	NULL
restricted	NULL
to	NULL
the	NULL
basolateral	NULL
surface	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
a	NULL
highly	NULL
polarized	NULL
functional	NULL
architecture	NULL
for	NULL
antigen	NULL
processing	NULL
and	NULL
presentation	NULL
by	NULL
intestinal	NULL
epithelial	NULL
cells	NULL
,	NULL
and	NULL
suggest	NULL
that	NULL
the	NULL
functional	NULL
outcome	NULL
of	NULL
antigen	NULL
processing	NULL
by	NULL
the	NULL
intestinal	NULL
epithelium	NULL
is	NULL
both	NULL
dependent	NULL
on	NULL
the	NULL
cellular	NULL
surface	NULL
at	NULL
which	NULL
the	NULL
foreign	NULL
antigen	NULL
is	NULL
internalized	NULL
and	NULL
by	NULL
the	NULL
underlying	NULL
degree	NULL
of	NULL
mucosal	NULL
in-flammation	NULL
.	NULL

(	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

1998	NULL
.	NULL

102:792-803	NULL
.	NULL
)	NULL

Key	NULL
words	NULL
:	NULL
intestinal	NULL
epithelium	NULL
«	NULL
HLA	NULL
class	NULL
II	NULL
«	NULL
cell	NULL
polarity	NULL
«	NULL
oral	NULL
tolerance	NULL
«	NULL
inflammatory	NULL
bowel	NULL
disease	NULL
Introduction	NULL
The	NULL
intestinal	NULL
epithelium	NULL
is	NULL
composed	NULL
of	NULL
polarized	NULL
epithelial	NULL
cells	NULL
that	NULL
provide	NULL
a	NULL
crucial	NULL
barrier	NULL
function	NULL
.	NULL

This	NULL
single	NULL
cell	NULL
layer	NULL
separates	NULL
a	NULL
myriad	NULL
of	NULL
bacterial	NULL
and	NULL
food	NULL
antigens	NULL
in	NULL
the	NULL
lumen	NULL
of	NULL
the	NULL
gastrointestinal	NULL
tract	NULL
from	NULL
the	NULL
largest	NULL
complement	NULL
of	NULL
lymphocytes	NULL
in	NULL
the	NULL
body	NULL
,	NULL
which	NULL
defines	NULL
the	NULL
gut-associ-	NULL
Address	NULL
correspondence	NULL
to	NULL
Robert	NULL
M.	NULL
Hershberg	NULL
,	NULL
Virginia	NULL
Mason	NULL
Research	NULL
Center	NULL
,	NULL
1000	NULL
Seneca	NULL
Street	NULL
,	NULL
Seattle	NULL
,	NULL
WA	NULL
98101	NULL
.	NULL

Phone	NULL
:	NULL
206-583-6525	NULL
;	NULL
FAX	NULL
:	NULL
206-223-7543	NULL
;	NULL
E-mail	NULL
:	NULL
hersh	NULL
@	NULL
u.washington.edu	NULL
Received	NULL
for	NULL
publication	NULL
24	NULL
February	NULL
1998	NULL
and	NULL
accepted	NULL
in	NULL
revised	NULL
form	NULL
11	NULL
June	NULL
1998.	NULL
ated	NULL
lymphoid	NULL
tissue	NULL
(	NULL
GALT	NULL
)	NULL
.	NULL
'	NULL

In	NULL
addition	NULL
to	NULL
its	NULL
crucial	NULL
role	NULL
in	NULL
barrier	NULL
function	NULL
and	NULL
in	NULL
nutrient	NULL
and	NULL
ion	NULL
transport	NULL
,	NULL
the	NULL
intestinal	NULL
epithelium	NULL
is	NULL
an	NULL
active	NULL
component	NULL
in	NULL
the	NULL
complex	NULL
immuno-regulation	NULL
of	NULL
the	NULL
GALT	NULL
.	NULL

Intestinal	NULL
epithelial	NULL
cells	NULL
(	NULL
IECs	NULL
)	NULL
secrete	NULL
a	NULL
wide	NULL
variety	NULL
of	NULL
cytokines	NULL
,	NULL
both	NULL
constitutively	NULL
and	NULL
after	NULL
invasion	NULL
with	NULL
bacterial	NULL
pathogens	NULL
(	NULL
1	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
IECs	NULL
have	NULL
extensive	NULL
cellular	NULL
contact	NULL
with	NULL
several	NULL
distinct	NULL
populations	NULL
of	NULL
T	NULL
lymphocytes	NULL
both	NULL
within	NULL
the	NULL
epithelium	NULL
(	NULL
intestinal	NULL
epithelial	NULL
lymphocytes	NULL
)	NULL
and	NULL
in	NULL
the	NULL
underlying	NULL
lamina	NULL
propria	NULL
(	NULL
lamina	NULL
propria	NULL
lymphocytes	NULL
)	NULL
.	NULL

Whereas	NULL
several	NULL
molecules	NULL
that	NULL
mediate	NULL
the	NULL
physical	NULL
interaction	NULL
between	NULL
T	NULL
cells	NULL
and	NULL
intestinal	NULL
epithelial	NULL
cells	NULL
have	NULL
been	NULL
identified	NULL
(	NULL
2	NULL
)	NULL
,	NULL
the	NULL
functional	NULL
consequences	NULL
of	NULL
these	NULL
interactions	NULL
are	NULL
not	NULL
well	NULL
understood	NULL
.	NULL

Recent	NULL
studies	NULL
in	NULL
experimental	NULL
systems	NULL
of	NULL
both	NULL
oral	NULL
tolerance	NULL
(	NULL
3-5	NULL
)	NULL
and	NULL
inflammatory	NULL
bowel	NULL
disease	NULL
(	NULL
6	NULL
)	NULL
have	NULL
underscored	NULL
the	NULL
importance	NULL
of	NULL
mucosal	NULL
CD4*	NULL
lymphocyte	NULL
re-sponses	NULL
.	NULL

Because	NULL
the	NULL
surface	NULL
expression	NULL
of	NULL
class	NULL
II	NULL
molecules	NULL
is	NULL
essential	NULL
in	NULL
cells	NULL
capable	NULL
of	NULL
functioning	NULL
as	NULL
antigen-presenting	NULL
cells	NULL
(	NULL
APCs	NULL
)	NULL
to	NULL
CD4*	NULL
T	NULL
cells	NULL
(	NULL
7	NULL
)	NULL
,	NULL
it	NULL
is	NULL
noteworthy	NULL
that	NULL
numerous	NULL
reports	NULL
have	NULL
described	NULL
the	NULL
low	NULL
level	NULL
of	NULL
HLA	NULL
class	NULL
II	NULL
antigens	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
normal	NULL
IEC	NULL
and	NULL
the	NULL
increased	NULL
expression	NULL
of	NULL
these	NULL
molecules	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
pathological	NULL
conditions	NULL
,	NULL
including	NULL
inflammatory	NULL
bowel	NULL
disease	NULL
(	NULL
8	NULL
)	NULL
,	NULL
graft-versus-host	NULL
disease	NULL
(	NULL
9	NULL
)	NULL
,	NULL
and	NULL
Celiac	NULL
disease	NULL
(	NULL
10	NULL
)	NULL
.	NULL

The	NULL
cellular	NULL
machinery	NULL
for	NULL
efficient	NULL
processing	NULL
and	NULL
presentation	NULL
of	NULL
antigen	NULL
to	NULL
CD4®	NULL
T	NULL
lymphocytes	NULL
via	NULL
HLA	NULL
class	NULL
II	NULL
includes	NULL
a	NULL
variety	NULL
of	NULL
cellular	NULL
proteases	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
invariant	NULL
chain	NULL
(	NULL
Ii	NULL
)	NULL
and	NULL
HLA-DM	NULL
heterodimer	NULL
(	NULL
reviewed	NULL
in	NULL
references	NULL
11	NULL
and	NULL
12	NULL
)	NULL
.	NULL

Indeed	NULL
,	NULL
Kaiser-lian	NULL
et	NULL
al	NULL
.	NULL

have	NULL
shown	NULL
that	NULL
murine	NULL
IECs	NULL
can	NULL
function	NULL
as	NULL
APCs	NULL
to	NULL
CD4*	NULL
cells	NULL
(	NULL
13	NULL
)	NULL
.	NULL

We	NULL
have	NULL
recently	NULL
characterized	NULL
the	NULL
class	NULL
II	NULL
pathway	NULL
in	NULL
several	NULL
human	NULL
IEC	NULL
lines	NULL
,	NULL
and	NULL
shown	NULL
that	NULL
these	NULL
cells	NULL
can	NULL
process	NULL
and	NULL
present	NULL
antigen	NULL
to	NULL
CD4*	NULL
T	NULL
cells	NULL
in	NULL
a	NULL
pathway	NULL
modulated	NULL
by	NULL
the	NULL
expression	NULL
of	NULL
Ii	NULL
and	NULL
HLA-DM	NULL
(	NULL
14	NULL
)	NULL
.	NULL

An	NULL
important	NULL
issue	NULL
arises	NULL
when	NULL
considering	NULL
the	NULL
in	NULL
vivo	NULL
APC	NULL
function	NULL
of	NULL
IECs	NULL
due	NULL
to	NULL
the	NULL
tight	NULL
junctions	NULL
that	NULL
restrict	NULL
the	NULL
passage	NULL
of	NULL
macromolecules	NULL
between	NULL
individual	NULL
cells	NULL
.	NULL

Specifically	NULL
,	NULL
the	NULL
apical	NULL
(	NULL
or	NULL
luminal	NULL
)	NULL
surface	NULL
of	NULL
the	NULL
IEC	NULL
is	NULL
selectively	NULL
exposed	NULL
to	NULL
high	NULL
concentrations	NULL
of	NULL
foreign	NULL
antigen	NULL
;	NULL
yet	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
HLA	NULL
class	NULL
II	NULL
antigens	NULL
on	NULL
epithelial	NULL
cells	NULL
in	NULL
tissue	NULL
sections	NULL
of	NULL
intestinal	NULL
mucosa	NULL
from	NULL
human	NULL
(	NULL
15	NULL
,	NULL
16	NULL
)	NULL
and	NULL
rat	NULL
(	NULL
17	NULL
)	NULL
was	NULL
observed	NULL
to	NULL
be	NULL
restricted	NULL
to	NULL
the	NULL
basolateral	NULL
surface	NULL
.	NULL

The	NULL
situation	NULL
is	NULL
not	NULL
static	NULL
,	NULL
however	NULL
,	NULL
because	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
inflammatory	NULL
cytokines	NULL
such	NULL
as	NULL
y-interferon	NULL
(	NULL
y-IFN	NULL
)	NULL
,	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

©	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Clinical	NULL
Investigation	NULL
,	NULL
Inc.	NULL
0021-9738/98/08/0792/12	NULL
$	NULL
2.00	NULL
Volume	NULL
102	NULL
,	NULL
Number	NULL
4	NULL
,	NULL
August	NULL
1998	NULL
,	NULL
792-803	NULL
http	NULL
:	NULL
//www.jci.org	NULL
792	NULL
Hershberg	NULL
et	NULL
al	NULL
.	NULL

1	NULL
.	NULL

Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
APC	NULL
,	NULL
antigen-presenting	NULL
cell	NULL
;	NULL
CIITA	NULL
,	NULL
class	NULL
II	NULL
transactivator	NULL
;	NULL
GALT	NULL
,	NULL
gut-associated	NULL
lymphoid	NULL
tissue	NULL
;	NULL
HRP	NULL
,	NULL
horseradish	NULL
peroxidase	NULL
;	NULL
IEC	NULL
,	NULL
intestinal	NULL
epithelial	NULL
cell	NULL
;	NULL
Ii	NULL
,	NULL
invariant	NULL
chain	NULL
;	NULL
MDCK	NULL
,	NULL
Madine-Darby	NULL
canine	NULL
kidney	NULL
;	NULL
TER	NULL
,	NULL
trans-epithelial	NULL
resistance	NULL
;	NULL
TT	NULL
,	NULL
tetanus	NULL
toxoid	NULL
.	NULL

the	NULL
barrier	NULL
function	NULL
of	NULL
the	NULL
epithelium	NULL
is	NULL
significantly	NULL
impaired	NULL
(	NULL
18	NULL
)	NULL
.	NULL

The	NULL
resulting	NULL
increase	NULL
in	NULL
paracellular	NULL
transport	NULL
of	NULL
luminal	NULL
antigens	NULL
would	NULL
result	NULL
in	NULL
the	NULL
concurrent	NULL
exposure	NULL
of	NULL
both	NULL
the	NULL
apical	NULL
and	NULL
basolateral	NULL
surfaces	NULL
of	NULL
the	NULL
cell	NULL
to	NULL
foreign	NULL
antigens	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
differences	NULL
in	NULL
the	NULL
cellular	NULL
trafficking	NULL
of	NULL
antigen	NULL
after	NULL
exposure	NULL
to	NULL
either	NULL
the	NULL
apical	NULL
or	NULL
basolateral	NULL
surfaces	NULL
of	NULL
polarized	NULL
,	NULL
HLA	NULL
class	NULL
II	NULL
positive	NULL
epithelial	NULL
cells	NULL
may	NULL
have	NULL
functional	NULL
consequences	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
adjacent	NULL
and	NULL
sub-jacent	NULL
T	NULL
lymphocytes	NULL
.	NULL

Conceivably	NULL
,	NULL
these	NULL
differences	NULL
might	NULL
tilt	NULL
the	NULL
delicate	NULL
balance	NULL
in	NULL
the	NULL
GALT	NULL
away	NULL
from	NULL
immune	NULL
tolerance	NULL
towards	NULL
the	NULL
inflammatory	NULL
response	NULL
seen	NULL
in	NULL
the	NULL
intestinal	NULL
mucosa	NULL
in	NULL
a	NULL
wide	NULL
variety	NULL
of	NULL
clinical	NULL
disorders	NULL
.	NULL

Here	NULL
we	NULL
describe	NULL
a	NULL
model	NULL
system	NULL
to	NULL
study	NULL
the	NULL
physiologic	NULL
interaction	NULL
between	NULL
polarized	NULL
epithelial	NULL
cells	NULL
and	NULL
CD4*	NULL
T	NULL
lymphocytes	NULL
,	NULL
and	NULL
investigate	NULL
the	NULL
polar	NULL
nature	NULL
of	NULL
HLA	NULL
class	NULL
II	NULL
antigen	NULL
processing	NULL
and	NULL
presentation	NULL
by	NULL
IECs	NULL
.	NULL

Using	NULL
the	NULL
polarized	NULL
human	NULL
IEC	NULL
line	NULL
T84	NULL
engineered	NULL
to	NULL
constitutively	NULL
express	NULL
HLA-DR	NULL
molecules	NULL
,	NULL
we	NULL
demonstrate	NULL
the	NULL
restricted	NULL
expression	NULL
of	NULL
HLA	NULL
class	NULL
II	NULL
antigens	NULL
at	NULL
the	NULL
basolateral	NULL
surface	NULL
of	NULL
the	NULL
cell	NULL
,	NULL
mimicking	NULL
the	NULL
topologically	NULL
restricted	NULL
expression	NULL
pattern	NULL
seen	NULL
in	NULL
vivo	NULL
.	NULL

Using	NULL
tetanus	NULL
toxoid	NULL
specific	NULL
and	NULL
HLA-DR-restricted	NULL
T	NULL
cells	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
,	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
Ii	NULL
and	NULL
HLA-DM	NULL
,	NULL
only	NULL
exposure	NULL
of	NULL
antigen	NULL
at	NULL
the	NULL
apical	NULL
surface	NULL
of	NULL
the	NULL
T84	NULL
HLA-DR	NULL
transfectants	NULL
is	NULL
capable	NULL
of	NULL
initiating	NULL
HLA	NULL
class	NULL
II	NULL
processing	NULL
and	NULL
presentation	NULL
.	NULL

However	NULL
,	NULL
when	NULL
the	NULL
T84	NULL
HLA-DR	NULL
transfectants	NULL
are	NULL
engineered	NULL
to	NULL
also	NULL
overexpress	NULL
the	NULL
class	NULL
II	NULL
transactivator	NULL
(	NULL
CIHITA	NULL
)	NULL
,	NULL
resulting	NULL
in	NULL
the	NULL
induced	NULL
expression	NULL
of	NULL
invariant	NULL
chain	NULL
and	NULL
HLA-DM	NULL
,	NULL
both	NULL
the	NULL
apical	NULL
and	NULL
basolateral	NULL
surface	NULL
can	NULL
initiate	NULL
processing	NULL
.	NULL

These	NULL
data	NULL
are	NULL
consistent	NULL
with	NULL
a	NULL
model	NULL
in	NULL
which	NULL
both	NULL
the	NULL
polarized	NULL
exposure	NULL
of	NULL
antigen	NULL
and	NULL
the	NULL
underlying	NULL
level	NULL
of	NULL
mucosal	NULL
inflammation	NULL
may	NULL
dramatically	NULL
modulate	NULL
the	NULL
functional	NULL
outcome	NULL
of	NULL
the	NULL
class	NULL
II	NULL
antigen	NULL
processing	NULL
by	NULL
the	NULL
intestinal	NULL
epithelium	NULL
.	NULL

Methods	NULL
Cells	NULL
and	NULL
transfectants	NULL
.	NULL

The	NULL
T84	NULL
cell	NULL
line	NULL
(	NULL
ATCC	NULL
CCL-248	NULL
)	NULL
was	NULL
determined	NULL
by	NULL
reverse	NULL
dot	NULL
blot	NULL
hybridization	NULL
with	NULL
HLA-DR-specific	NULL
probes	NULL
to	NULL
be	NULL
:	NULL
DRB1*0101	NULL
,	NULL
/09012	NULL
and	NULL
DRB4	NULL
#	NULL
*0101	NULL
.	NULL

HLA-DRB1*0401-expressing	NULL
transfectants	NULL
were	NULL
generated	NULL
by	NULL
retroviral	NULL
infection	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Where	NULL
indicated	NULL
,	NULL
the	NULL
T84	NULL
HLA-DR	NULL
transfectants	NULL
were	NULL
superinfected	NULL
with	NULL
a	NULL
recombinant	NULL
retrovirus	NULL
expressing	NULL
the	NULL
class	NULL
II	NULL
transactivator	NULL
,	NULL
CIITA	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Dividing	NULL
T84	NULL
HLA-DRB1*0401	NULL
transfectants	NULL
were	NULL
exposed	NULL
to	NULL
fresh	NULL
recombinant	NULL
CIITA	NULL
virus	NULL
daily	NULL
for	NULL
7	NULL
d	NULL
and	NULL
infection	NULL
was	NULL
verified	NULL
as	NULL
described	NULL
in	NULL
Results	NULL
.	NULL

T84	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
DME	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
vol/vol	NULL
FBS	NULL
,	NULL
non-essen-tial	NULL
amino	NULL
acids	NULL
(	NULL
GIBCO	NULL
BRL	NULL
,	NULL
Gaithersburg	NULL
,	NULL
MD	NULL
)	NULL
,	NULL
20	NULL
mM	NULL
glutamine	NULL
,	NULL
and	NULL
penicillin/streptomycin	NULL
.	NULL

The	NULL
EBV	NULL
-transformed	NULL
B-LCL	NULL
BSM	NULL
and	NULL
the	NULL
BXT	NULL
hybrid	NULL
T2	NULL
(	NULL
containing	NULL
a	NULL
homozygous	NULL
deletion	NULL
of	NULL
the	NULL
HLA	NULL
class	NULL
II	NULL
locus	NULL
including	NULL
the	NULL
region	NULL
encoding	NULL
HLA-DM	NULL
)	NULL
were	NULL
grown	NULL
in	NULL
RPMI	NULL
with	NULL
10	NULL
%	NULL
vol/vol	NULL
FBS	NULL
and	NULL
50	NULL
mM	NULL
B-mercaptoethanol	NULL
.	NULL

Confocal	NULL
microscopy	NULL
.	NULL

Cells	NULL
were	NULL
grown	NULL
on	NULL
borosilicate	NULL
chamber	NULL
coverslips	NULL
(	NULL
Lab-Tek	NULL
,	NULL
Nunc	NULL
,	NULL
Napierville	NULL
,	NULL
IL	NULL
)	NULL
or	NULL
on	NULL
polycarbonate	NULL
filter	NULL
inserts	NULL
(	NULL
6.5	NULL
mm	NULL
diameter	NULL
,	NULL
0.4	NULL
j	NULL
pore	NULL
size	NULL
;	NULL
Costar	NULL
,	NULL
Cambridge	NULL
,	NULL
MA	NULL
)	NULL
and	NULL
maintained	NULL
for	NULL
3-5	NULL
d	NULL
after	NULL
confluence	NULL
(	NULL
transepithelial	NULL
resistance	NULL
[	NULL
TER	NULL
]	NULL
>	NULL
1,000	NULL
ohms	NULL
em	NULL
?	NULL
)	NULL

.	NULL

Processing	NULL
of	NULL
the	NULL
cells	NULL
for	NULL
immunofluores-cence	NULL
was	NULL
done	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Cells	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
PBS	NULL
,	NULL
fixed	NULL
for	NULL
15	NULL
min	NULL
in	NULL
4	NULL
%	NULL
paraformaldehyde	NULL
in	NULL
PBS	NULL
,	NULL
washed	NULL
twice	NULL
in	NULL
PBS	NULL
,	NULL
and	NULL
incubated	NULL
for	NULL
30	NULL
min	NULL
in	NULL
50	NULL
mM	NULL
NH	NULL
,	NULL
Cl	NULL
to	NULL
quench	NULL
unreacted	NULL
aldehyde	NULL
groups	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
washed	NULL
twice	NULL
more	NULL
with	NULL
PBS	NULL
and	NULL
then	NULL
permeabilized	NULL
and	NULL
blocked	NULL
in	NULL
PBS	NULL
containing	NULL
0.1	NULL
%	NULL
Triton	NULL
X-100	NULL
and	NULL
5	NULL
%	NULL
BSA	NULL
(	NULL
PTB	NULL
)	NULL
for	NULL
30	NULL
min	NULL
.	NULL

Subsequently	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
primary	NULL
antibodies	NULL
(	NULL
anti-E-cadherin	NULL
and	NULL
anti-ZO-1	NULL
;	NULL
Zymed	NULL
Laboratories	NULL
,	NULL
San	NULL
Francisco	NULL
,	NULL
CA	NULL
)	NULL
;	NULL
anti-HLA	NULL
class	NULL
I	NULL
(	NULL
W6/32	NULL
,	NULL
kindly	NULL
provided	NULL
by	NULL
Daniel	NULL
Geraghty	NULL
,	NULL
Fred	NULL
Hutchinson	NULL
Cancer	NULL
Research	NULL
Center	NULL
,	NULL
Seattle	NULL
,	NULL
WA	NULL
)	NULL
;	NULL
anti-HLA-DR	NULL
(	NULL
L243	NULL
)	NULL
,	NULL
diluted	NULL
in	NULL
PTB	NULL
for	NULL
1-2	NULL
h	NULL
,	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
PBS	NULL
,	NULL
and	NULL
then	NULL
incubated	NULL
for	NULL
1	NULL
h	NULL
with	NULL
the	NULL
appropriate	NULL
fluorescent-conjugated	NULL
secondary	NULL
antibody	NULL
(	NULL
Oregon	NULL
green	NULL
goat	NULL
anti-rabbit	NULL
IgG	NULL
for	NULL
the	NULL
anti-2O-1	NULL
antibody	NULL
,	NULL
and	NULL
Rhodamine	NULL
goat	NULL
anti-mouse	NULL
IgG	NULL
for	NULL
the	NULL
others	NULL
;	NULL
Molecular	NULL
Probes	NULL
,	NULL
Eugene	NULL
,	NULL
OR	NULL
)	NULL
diluted	NULL
in	NULL
PTB	NULL
.	NULL

After	NULL
washing	NULL
with	NULL
PBS	NULL
three	NULL
times	NULL
,	NULL
the	NULL
coverslips	NULL
or	NULL
filters	NULL
(	NULL
cut	NULL
out	NULL
of	NULL
their	NULL
holders	NULL
and	NULL
placed	NULL
on	NULL
slides	NULL
)	NULL
were	NULL
mounted	NULL
and	NULL
then	NULL
covered	NULL
with	NULL
DABCO/glycerol/PBS	NULL
,	NULL
and	NULL
in	NULL
the	NULL
case	NULL
of	NULL
the	NULL
filters	NULL
,	NULL
coverslipped	NULL
and	NULL
sealed	NULL
before	NULL
microscopy	NULL
.	NULL

The	NULL
samples	NULL
were	NULL
analyzed	NULL
by	NULL
on	NULL
a	NULL
Molecular	NULL
Dynamics	NULL
Laser	NULL
Scanning	NULL
Microscope	NULL
Model	NULL
2001	NULL
(	NULL
Molecular	NULL
Dynamics	NULL
,	NULL
Sunnyvale	NULL
,	NULL
CA	NULL
)	NULL
equipped	NULL
with	NULL
an	NULL
Kr/Ar	NULL
laser	NULL
and	NULL
a	NULL
Nikon	NULL
60	NULL
%	NULL
NA	NULL
1.4	NULL
oil	NULL
lens	NULL
.	NULL

Images	NULL
were	NULL
collected	NULL
using	NULL
an	NULL
SGI	NULL
Iris	NULL
Indigo	NULL
4000	NULL
Workstation	NULL
(	NULL
Sili-con	NULL
Graphics	NULL
,	NULL
Mountain	NULL
View	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
final	NULL
images	NULL
were	NULL
prepared	NULL
using	NULL
Adobe	NULL
Photoshop	NULL
V3.0	NULL
.	NULL

All	NULL
images	NULL
were	NULL
processed	NULL
identically	NULL
.	NULL

Cell	NULL
surface-specific	NULL
biotinylation	NULL
,	NULL
immunoprecipitation	NULL
,	NULL
and	NULL
im-munoblotting	NULL
.	NULL

For	NULL
biotinylation	NULL
,	NULL
cells	NULL
were	NULL
grown	NULL
on	NULL
polycarbonate	NULL
filter	NULL
inserts	NULL
(	NULL
24	NULL
mm	NULL
diameter	NULL
,	NULL
0.4	NULL
q	NULL
pore	NULL
size	NULL
;	NULL
Costar	NULL
,	NULL
Cambridge	NULL
,	NULL
MA	NULL
)	NULL
until	NULL
TER	NULL
were	NULL
>	NULL
1,000	NULL
ohms	NULL
cm	NULL
'	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
labeled	NULL
either	NULL
apically	NULL
or	NULL
basolaterally	NULL
with	NULL
biotin	NULL
(	NULL
Calbiochem	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
20	NULL
)	NULL
.	NULL

After	NULL
biotinylation	NULL
,	NULL
cells	NULL
were	NULL
solubilized	NULL
in	NULL
Lysis	NULL
buffer	NULL
(	NULL
2.5	NULL
%	NULL
n-octylglucoside	NULL
,	NULL
0.1	NULL
M	NULL
Tris	NULL
,	NULL
pH	NULL
7.4	NULL
,	NULL
0.15	NULL
M	NULL
NaCl	NULL
,	NULL
2	NULL
mM	NULL
MgC	NULL
)	NULL
,	NULL
0.02	NULL
%	NULL
NaN	NULL
,	NULL
1	NULL
ug/ml	NULL
leupeptin	NULL
,	NULL
1	NULL
pg/ml	NULL
pepsta-tin	NULL
,	NULL
and	NULL
1	NULL
mM	NULL
PMSF	NULL
)	NULL
for	NULL
90	NULL
min	NULL
at	NULL
4°C	NULL
with	NULL
frequent	NULL
titration	NULL
.	NULL

The	NULL
lysates	NULL
were	NULL
centrifuged	NULL
at	NULL
14,000	NULL
g	NULL
for	NULL
10	NULL
min	NULL
and	NULL
the	NULL
supernatants	NULL
retained	NULL
for	NULL
immunoprecipitation	NULL
.	NULL

100	NULL
pg	NULL
of	NULL
the	NULL
supernatants	NULL
were	NULL
incubated	NULL
with	NULL
20	NULL
g	NULL
of	NULL
antibody	NULL
overnight	NULL
at	NULL
4°C	NULL
.	NULL

50	NULL
microliters	NULL
of	NULL
Protein	NULL
G	NULL
agarose	NULL
(	NULL
prewashed	NULL
in	NULL
Lysis	NULL
buffer	NULL
containing	NULL
5	NULL
%	NULL
BSA	NULL
)	NULL
was	NULL
added	NULL
to	NULL
the	NULL
samples	NULL
and	NULL
they	NULL
were	NULL
further	NULL
incubated	NULL
at	NULL
4°C	NULL
for	NULL
90	NULL
min	NULL
.	NULL

The	NULL
Protein	NULL
G	NULL
agarose	NULL
was	NULL
washed	NULL
four	NULL
times	NULL
with	NULL
Lysis	NULL
buffer	NULL
and	NULL
the	NULL
bound	NULL
material	NULL
eluted	NULL
by	NULL
boiling	NULL
for	NULL
10	NULL
min	NULL
in	NULL
reducing	NULL
SDS-PAGE	NULL
sample	NULL
buffer	NULL
.	NULL

The	NULL
eluted	NULL
samples	NULL
were	NULL
fractionated	NULL
on	NULL
a	NULL
10	NULL
%	NULL
Tris-glycine	NULL
gel	NULL
,	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
,	NULL
blocked	NULL
overnight	NULL
in	NULL
PBS	NULL
containing	NULL
0.1	NULL
%	NULL
Tween	NULL
20	NULL
and	NULL
5	NULL
%	NULL
BSA	NULL
at	NULL
4°C	NULL
,	NULL
and	NULL
the	NULL
biotinylated	NULL
proteins	NULL
were	NULL
detected	NULL
using	NULL
streptavidin-horseradish	NULL
peroxide	NULL
(	NULL
HRP	NULL
;	NULL
Jackson	NULL
Labs	NULL
,	NULL
Bar	NULL
Harbor	NULL
,	NULL
ME	NULL
)	NULL
and	NULL
a	NULL
chemilumi-nescent	NULL
substrate	NULL
for	NULL
peroxidase	NULL
(	NULL
ECL	NULL
;	NULL
Amersham	NULL
Corp.	NULL
,	NULL
Arlington	NULL
Heights	NULL
,	NULL
IL	NULL
)	NULL
followed	NULL
by	NULL
exposure	NULL
to	NULL
film	NULL
.	NULL

Immunoblot	NULL
analyses	NULL
of	NULL
invariant	NULL
chain	NULL
using	NULL
the	NULL
mAb	NULL
Pin-1	NULL
and	NULL
HLA-DMB	NULL
using	NULL
anti-HLA-DMB	NULL
rabbit	NULL
serum	NULL
(	NULL
both	NULL
kindly	NULL
provided	NULL
by	NULL
Peter	NULL
Cresswell	NULL
,	NULL
Yale	NULL
University	NULL
,	NULL
New	NULL
Haven	NULL
,	NULL
CT	NULL
)	NULL
,	NULL
and	NULL
for	NULL
HLA-DMa	NULL
«	NULL
using	NULL
anti-HLA-DMa	NULL
«	NULL
rabbit	NULL
serum	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
Alexander	NULL
Rudensky	NULL
,	NULL
University	NULL
of	NULL
Washington	NULL
,	NULL
Seattle	NULL
,	NULL
WA	NULL
)	NULL
were	NULL
performed	NULL
using	NULL
goat	NULL
anti-mouse	NULL
or	NULL
goat	NULL
anti-rabbit	NULL
IgG	NULL
+	NULL
IgM	NULL
(	NULL
Jackson	NULL
ImmunoResearch	NULL
Laboratories	NULL
,	NULL
Inc.	NULL
)	NULL
and	NULL
chemilumines-cence	NULL
as	NULL
described	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Analysis	NULL
of	NULL
barrier	NULL
function	NULL
.	NULL

300	NULL
X	NULL
10°	NULL
T84	NULL
cells	NULL
were	NULL
plated	NULL
on	NULL
upright	NULL
transwell	NULL
filters	NULL
(	NULL
3.0	NULL
m	NULL
pore	NULL
size	NULL
;	NULL
Costar	NULL
)	NULL
exposing	NULL
the	NULL
apical	NULL
surface	NULL
to	NULL
the	NULL
top	NULL
chamber	NULL
,	NULL
or	NULL
on	NULL
upside	NULL
down	NULL
filters	NULL
that	NULL
were	NULL
subsequently	NULL
inverted	NULL
exposing	NULL
the	NULL
basolateral	NULL
surface	NULL
to	NULL
the	NULL
top	NULL
chamber	NULL
.	NULL

Cells	NULL
were	NULL
cultured	NULL
until	NULL
TER	NULL
exceeded	NULL
1,000	NULL
ohms	NULL
em	NULL
(	NULL
generally	NULL
5-7	NULL
d	NULL
)	NULL
before	NULL
use	NULL
in	NULL
antigen	NULL
presentation	NULL
or	NULL
processing	NULL
experiments	NULL
.	NULL

TER	NULL
was	NULL
assessed	NULL
using	NULL
an	NULL
epithelial	NULL
voltometer	NULL
(	NULL
EVOM	NULL
,	NULL
Sarasota	NULL
,	NULL
FL	NULL
)	NULL
and	NULL
converted	NULL
to	NULL
ohms	NULL
em	NULL
``	NULL
based	NULL
on	NULL
the	NULL
surface	NULL
area	NULL
of	NULL
the	NULL
transwell	NULL
filter	NULL
.	NULL

Bulk	NULL
protein	NULL
transport	NULL
was	NULL
assessed	NULL
using	NULL
intact	NULL
horseradish	NULL
peroxidase	NULL
,	NULL
as	NULL
described	NULL
(	NULL
21	NULL
)	NULL
.	NULL

T	NULL
cells	NULL
and	NULL
antigen-processing/presentation	NULL
assays	NULL
.	NULL

Antigen-specific	NULL
,	NULL
HLA-DRB1*0401-restricted	NULL
T	NULL
cell	NULL
hybridomas	NULL
were	NULL
kindly	NULL
provided	NULL
by	NULL
Dennis	NULL
Zaller	NULL
(	NULL
Merck	NULL
Research	NULL
Labs	NULL
.	NULL

,	NULL
Rahway	NULL
,	NULL
NJ	NULL
)	NULL
.	NULL

The	NULL
tetanus	NULL
toxoid	NULL
(	NULL
TT	NULL
)	NULL
-specific	NULL
T	NULL
cell	NULL
hybrid	NULL
49.23.2	NULL
,	NULL
and	NULL
the	NULL
HSA-specific	NULL
T	NULL
cell	NULL
hybrid	NULL
17.9	NULL
were	NULL
generated	NULL
after	NULL
immunization	NULL
of	NULL
a	NULL
DR4w4	NULL
transgenic	NULL
mouse	NULL
with	NULL
tetanus	NULL
or	NULL
HSA	NULL
,	NULL
respectively	NULL
(	NULL
22	NULL
)	NULL
.	NULL

TT	NULL
(	NULL
Wyeth	NULL
Refined	NULL
Concentrate	NULL
,	NULL
Wyeth-Ayerst	NULL
,	NULL
Swiftwater	NULL
,	NULL
PA	NULL
)	NULL
was	NULL
extensively	NULL
dialyzed	NULL
at	NULL
4°C	NULL
against	NULL
PBS	NULL
.	NULL

TT	NULL
-specific	NULL
,	NULL
HLA-DRB1*0401-restricted	NULL
human	NULL
T	NULL
cell	NULL
clones	NULL
were	NULL
generated	NULL
from	NULL
the	NULL
peripheral	NULL
blood	NULL
of	NULL
a	NULL
healthy	NULL
HLA-DRB1*0401	NULL
individual	NULL
as	NULL
previously	NULL
detailed	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Clonality	NULL
of	NULL
the	NULL
T	NULL
cells	NULL
was	NULL
confirmed	NULL
by	NULL
RT-PCR	NULL
using	NULL
a	NULL
panel	NULL
of	NULL
Polarity	NULL
and	NULL
HLA	NULL
Class	NULL
II	NULL
_	NULL
793	NULL
TCR	NULL
Va	NULL
and	NULL
VB	NULL
primers	NULL
as	NULL
described	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Clone	NULL
2	NULL
was	NULL
found	NULL
to	NULL
use	NULL
the	NULL
gene	NULL
segment	NULL
encoding	NULL
VB5.2	NULL
and	NULL
clone	NULL
4	NULL
was	NULL
found	NULL
to	NULL
use	NULL
the	NULL
gene	NULL
segment	NULL
encoding	NULL
VB13	NULL
.	NULL

For	NULL
clone	NULL
4	NULL
,	NULL
these	NULL
data	NULL
were	NULL
confirmed	NULL
using	NULL
a	NULL
VB13	NULL
subfamily-specific	NULL
monoclonal	NULL
antibody	NULL
(	NULL
Endogen	NULL
,	NULL
Inc.	NULL
,	NULL
Cambridge	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

For	NULL
antigen-processing	NULL
and/or	NULL
presentation	NULL
assays	NULL
,	NULL
T84	NULL
cells	NULL
were	NULL
plated	NULL
on	NULL
transwells	NULL
,	NULL
and	NULL
the	NULL
monolayers	NULL
were	NULL
verified	NULL
to	NULL
have	NULL
a	NULL
TER	NULL
>	NULL
1,000	NULL
ohms	NULL
cm	NULL
?	NULL

at	NULL
the	NULL
start	NULL
of	NULL
the	NULL
experiment	NULL
.	NULL

For	NULL
the	NULL
peptide	NULL
presentation	NULL
experiments	NULL
,	NULL
HSA	NULL
peptide	NULL
was	NULL
added	NULL
to	NULL
the	NULL
top	NULL
chamber	NULL
of	NULL
upright	NULL
or	NULL
inverted	NULL
transwell	NULL
cultures	NULL
for	NULL
30	NULL
min	NULL
,	NULL
followed	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
100	NULL
x	NULL
10°	NULL
HSA-specific	NULL
hybridoma	NULL
cells	NULL
.	NULL

Supernatent	NULL
from	NULL
the	NULL
co-culture	NULL
was	NULL
collected	NULL
after	NULL
24	NULL
h	NULL
and	NULL
assayed	NULL
for	NULL
IL-2	NULL
using	NULL
the	NULL
HT-2	NULL
cell	NULL
line	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
14	NULL
)	NULL
.	NULL

For	NULL
the	NULL
processing	NULL
experiments	NULL
,	NULL
TT	NULL
was	NULL
applied	NULL
to	NULL
the	NULL
upper	NULL
or	NULL
lower	NULL
chamber	NULL
of	NULL
inverted	NULL
transwell	NULL
monolayers	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
resulting	NULL
in	NULL
basolateral	NULL
or	NULL
apical	NULL
exposure	NULL
to	NULL
antigen	NULL
,	NULL
respectively	NULL
.	NULL

After	NULL
4	NULL
h	NULL
,	NULL
the	NULL
antigen	NULL
was	NULL
removed	NULL
and	NULL
100	NULL
x	NULL
10°	NULL
TT-specific	NULL
T	NULL
cell	NULL
hybridoma	NULL
or	NULL
T	NULL
cell	NULL
clones	NULL
were	NULL
applied	NULL
to	NULL
the	NULL
top	NULL
chamber	NULL
and	NULL
co-cultured	NULL
with	NULL
the	NULL
T84	NULL
cells	NULL
for	NULL
24	NULL
h.	NULL
The	NULL
supernatant	NULL
was	NULL
collected	NULL
after	NULL
24	NULL
h	NULL
and	NULL
assayed	NULL
for	NULL
IL-2	NULL
using	NULL
HT-2	NULL
cells	NULL
.	NULL

For	NULL
the	NULL
drug	NULL
experiments	NULL
,	NULL
cells	NULL
were	NULL
prepulsed	NULL
with	NULL
drug	NULL
from	NULL
both	NULL
the	NULL
apical	NULL
and	NULL
basolateral	NULL
surfaces	NULL
for	NULL
30	NULL
min	NULL
before	NULL
adding	NULL
antigen	NULL
and	NULL
the	NULL
drug	NULL
was	NULL
present	NULL
during	NULL
antigen	NULL
pulsing	NULL
.	NULL

Drug	NULL
was	NULL
removed	NULL
from	NULL
both	NULL
chambers	NULL
with	NULL
the	NULL
removal	NULL
of	NULL
antigen	NULL
.	NULL

All	NULL
drugs	NULL
were	NULL
purchased	NULL
from	NULL
Sigma	NULL
Chemical	NULL
Co.	NULL
(	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
.	NULL

For	NULL
the	NULL
assays	NULL
with	NULL
the	NULL
T	NULL
cell	NULL
clones	NULL
,	NULL
the	NULL
T	NULL
cells	NULL
were	NULL
removed	NULL
from	NULL
the	NULL
transwells	NULL
after	NULL
24	NULL
h	NULL
,	NULL
transferred	NULL
to	NULL
96-well	NULL
flat	NULL
bottom	NULL
plates	NULL
,	NULL
and	NULL
cultured	NULL
for	NULL
48	NULL
h	NULL
in	NULL
RPMI	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
vol/vol	NULL
FBS	NULL
without	NULL
the	NULL
addition	NULL
of	NULL
exogenous	NULL
IL-2	NULL
.	NULL

1.0	NULL
Ci	NULL
of	NULL
[	NULL
H	NULL
]	NULL
-thymi-dine	NULL
was	NULL
present	NULL
during	NULL
the	NULL
final	NULL
16	NULL
h	NULL
of	NULL
culture	NULL
,	NULL
and	NULL
radiolabeled	NULL
load	NULL
”	NULL
ya	NULL
“	NULL
.	NULL

.	NULL

“	NULL
.\\	NULL
$	NULL
.	NULL

‘	NULL
1-.1\|1lx	NULL
'	NULL
u|	NULL
<	NULL
4-Basal	NULL
w	NULL
»	NULL
ms	NULL
d—Apit	NULL
'	NULL
u	NULL
]	NULL
<	NULL
4Basal	NULL
incorporation	NULL
was	NULL
measured	NULL
by	NULL
scintillation	NULL
spectroscopy	NULL
.	NULL

y-IFN	NULL
(	NULL
Genzyme	NULL
,	NULL
Cambridge	NULL
,	NULL
MA	NULL
)	NULL
was	NULL
prepared	NULL
and	NULL
used	NULL
according	NULL
to	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

Results	NULL
HLA	NULL
expression	NULL
is	NULL
largely	NULL
restricted	NULL
to	NULL
the	NULL
basolateral	NULL
surface	NULL
of	NULL
polarized	NULL
T84	NULL
cells	NULL
.	NULL

The	NULL
intestinal	NULL
epithelial	NULL
cell	NULL
line	NULL
T84	NULL
forms	NULL
polarized	NULL
monolayers	NULL
in	NULL
vitro	NULL
and	NULL
has	NULL
been	NULL
used	NULL
extensively	NULL
as	NULL
a	NULL
model	NULL
to	NULL
investigate	NULL
a	NULL
variety	NULL
of	NULL
physiologic	NULL
and	NULL
im-munologic	NULL
properties	NULL
of	NULL
the	NULL
intestinal	NULL
epithelium	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
1	NULL
,	NULL
18	NULL
,	NULL
24	NULL
)	NULL
.	NULL

To	NULL
study	NULL
the	NULL
HLA	NULL
class	NULL
II	NULL
antigen	NULL
processing	NULL
pathway	NULL
in	NULL
a	NULL
manner	NULL
independent	NULL
of	NULL
the	NULL
cytokines	NULL
required	NULL
to	NULL
induce	NULL
class	NULL
II	NULL
expression	NULL
in	NULL
this	NULL
cell	NULL
line	NULL
,	NULL
we	NULL
used	NULL
retroviral-mediated	NULL
gene	NULL
transfer	NULL
to	NULL
generate	NULL
T84	NULL
cells	NULL
that	NULL
constitutively	NULL
express	NULL
surface	NULL
HLA-DR	NULL
molecules	NULL
,	NULL
and	NULL
demonstrated	NULL
that	NULL
these	NULL
cells	NULL
could	NULL
both	NULL
process	NULL
and	NULL
present	NULL
antigen	NULL
to	NULL
CD4*	NULL
T	NULL
lymphocytes	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Previous	NULL
studies	NULL
addressing	NULL
the	NULL
distribution	NULL
of	NULL
HLA	NULL
class	NULL
II	NULL
on	NULL
the	NULL
intestinal	NULL
epithelium	NULL
in	NULL
vivo	NULL
have	NULL
observed	NULL
the	NULL
expression	NULL
of	NULL
these	NULL
molecules	NULL
to	NULL
be	NULL
restricted	NULL
to	NULL
the	NULL
basolateral	NULL
surface	NULL
(	NULL
15-17	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
T84	NULL
HLA-DR	NULL
transfectants	NULL
would	NULL
be	NULL
a	NULL
suitable	NULL
model	NULL
to	NULL
study	NULL
polarized	NULL
aspects	NULL
of	NULL
HLA	NULL
class	NULL
II	NULL
antigen	NULL
processing	NULL
and	NULL
presentation	NULL
,	NULL
we	NULL
used	NULL
confocal	NULL
microscopy	NULL
to	NULL
examine	NULL
the	NULL
polarized	NULL
expression	NULL
of	NULL
HLA-DR	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

As	NULL
seen	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
the	NULL
wild-type	NULL
T84	NULL
Figure	NULL
1	NULL
.	NULL

Expression	NULL
of	NULL
HLA-DR	NULL
molecules	NULL
in	NULL
polarized	NULL
T84	NULL
cells	NULL
is	NULL
restricted	NULL
to	NULL
the	NULL
basolateral	NULL
surface	NULL
.	NULL

Shown	NULL
are	NULL
confocal	NULL
microscopic	NULL
images	NULL
of	NULL
wild-type	NULL
T84	NULL
cells	NULL
(	NULL
top	NULL
,	NULL
bottom	NULL
left	NULL
)	NULL
,	NULL
T84	NULL
HLA-DRB1	NULL
#	NULL
*0401	NULL
(	NULL
bottom	NULL
middle	NULL
)	NULL
,	NULL
and	NULL
T84	NULL
HLA-DRB1*0401/CIITA	NULL
transfectants	NULL
(	NULL
bottom	NULL
right	NULL
)	NULL
stained	NULL
with	NULL
a	NULL
variety	NULL
of	NULL
mAb	NULL
.	NULL

Depicted	NULL
are	NULL
horizontal	NULL
(	NULL
X-Y	NULL
,	NULL
or	NULL
en	NULL
face	NULL
)	NULL
images	NULL
,	NULL
with	NULL
representative	NULL
vertical	NULL
(	NULL
X-Z	NULL
)	NULL
sections	NULL
below	NULL
.	NULL

In	NULL
all	NULL
pictures	NULL
cells	NULL
are	NULL
stained	NULL
with	NULL
anti-ZO-1	NULL
,	NULL
and	NULL
secondary	NULL
antibody	NULL
for	NULL
anti-ZO-1	NULL
was	NULL
goat	NULL
anti-rabbit	NULL
?	NULL
``	NULL

***	NULL
``	NULL
,	NULL
A1J	NULL
other	NULL
antibodies	NULL
listed	NULL
used	NULL
goat	NULL
anti-mouse	NULL
``	NULL
``	NULL
``	NULL
``	NULL
``	NULL
``	NULL
``	NULL
``	NULL
*	NULL
as	NULL
secondary	NULL
antibody	NULL
.	NULL

Co-staining	NULL
in	NULL
A	NULL
:	NULL
anti-E	NULL
cadherin	NULL
;	NULL
B	NULL
:	NULL
anti-MDR	NULL
;	NULL
C	NULL
:	NULL
anti-HLA	NULL
class	NULL
I	NULL
;	NULL
D-F	NULL
:	NULL
anti-HLA	NULL
class	NULL
IL	NULL
.	NULL

Cells	NULL
were	NULL
grown	NULL
on	NULL
transwells	NULL
until	NULL
TER	NULL
>	NULL
1,000	NULL
ohm	NULL
cm	NULL
,	NULL
and	NULL
fixed	NULL
,	NULL
permeabilized	NULL
,	NULL
and	NULL
stained	NULL
with	NULL
saturating	NULL
concentrations	NULL
of	NULL
antibody	NULL
as	NULL
outlined	NULL
in	NULL
Methods	NULL
.	NULL

Staining	NULL
with	NULL
secondary	NULL
antibodies	NULL
alone	NULL
was	NULL
used	NULL
to	NULL
define	NULL
background	NULL
staining	NULL
.	NULL

794	NULL
_	NULL
Hershberg	NULL
et	NULL
al	NULL
.	NULL

cells	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
a-d	NULL
)	NULL
as	NULL
well	NULL
as	NULL
the	NULL
T84	NULL
HLA-DR	NULL
transfectants	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
e	NULL
)	NULL
or	NULL
presence	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
f	NULL
)	NULL
of	NULL
the	NULL
directed	NULL
overexpression	NULL
of	NULL
the	NULL
class	NULL
II	NULL
transactivator	NULL
CIITA	NULL
(	NULL
see	NULL
be-low	NULL
)	NULL
form	NULL
monolayers	NULL
that	NULL
demonstrate	NULL
the	NULL
polarized	NULL
characteristics	NULL
of	NULL
a	NULL
number	NULL
of	NULL
proteins	NULL
and	NULL
the	NULL
presence	NULL
of	NULL
discrete	NULL
tight	NULL
junctions	NULL
.	NULL

Specifically	NULL
,	NULL
staining	NULL
with	NULL
antibodies	NULL
directed	NULL
against	NULL
the	NULL
tight	NULL
junction	NULL
complex	NULL
molecule	NULL
ZO-1	NULL
was	NULL
apical	NULL
and	NULL
junctional	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
a-f	NULL
)	NULL
,	NULL
whereas	NULL
the	NULL
staining	NULL
with	NULL
an	NULL
antibody	NULL
directed	NULL
against	NULL
E-cadherin	NULL
showed	NULL
the	NULL
characteristic	NULL
basolateral	NULL
pattern	NULL
,	NULL
with	NULL
more	NULL
staining	NULL
evident	NULL
along	NULL
the	NULL
lateral	NULL
aspects	NULL
of	NULL
the	NULL
cell	NULL
(	NULL
where	NULL
it	NULL
functions	NULL
in	NULL
cell	NULL
adhesion	NULL
)	NULL
than	NULL
along	NULL
the	NULL
basal	NULL
portion	NULL
of	NULL
the	NULL
cell	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
a	NULL
)	NULL
.	NULL

An	NULL
identical	NULL
pattern	NULL
of	NULL
E-cadherin	NULL
staining	NULL
was	NULL
seen	NULL
in	NULL
the	NULL
T84	NULL
HLA-DR	NULL
transfectants	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Staining	NULL
with	NULL
several	NULL
monoclonal	NULL
antibodies	NULL
specific	NULL
for	NULL
HLA-DR	NULL
revealed	NULL
predominantly	NULL
basolateral	NULL
surface	NULL
staining	NULL
,	NULL
with	NULL
the	NULL
most	NULL
prominent	NULL
staining	NULL
seen	NULL
along	NULL
the	NULL
basal	NULL
aspects	NULL
of	NULL
the	NULL
cell	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
e	NULL
and	NULL
f	NULL
)	NULL
.	NULL

As	NULL
seen	NULL
in	NULL
the	NULL
horizontal	NULL
X-Y	NULL
(	NULL
en	NULL
face	NULL
)	NULL
images	NULL
,	NULL
intracellular	NULL
class	NULL
II	NULL
staining	NULL
was	NULL
also	NULL
evident	NULL
and	NULL
vesicular	NULL
in	NULL
nature	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
e	NULL
and	NULL
f	NULL
)	NULL
.	NULL

This	NULL
pattern	NULL
was	NULL
not	NULL
HLA-DR	NULL
allele-specific	NULL
as	NULL
T84	NULL
cells	NULL
expressing	NULL
their	NULL
endogenous	NULL
HLA-DRB1	NULL
#	NULL
*0101	NULL
allele	NULL
(	NULL
either	NULL
after	NULL
treatment	NULL
with	NULL
y-IFN	NULL
or	NULL
with	NULL
directed	NULL
expression	NULL
of	NULL
CIITA	NULL
alone	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
the	NULL
transfected	NULL
DR4	NULL
allele	NULL
)	NULL
showed	NULL
an	NULL
identical	NULL
pattern	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
staining	NULL
seen	NULL
with	NULL
a	NULL
monoclonal	NULL
antibody	NULL
directed	NULL
against	NULL
HLA	NULL
class	NULL
I	NULL
revealed	NULL
a	NULL
pattern	NULL
similar	NULL
to	NULL
that	NULL
seen	NULL
with	NULL
antibodies	NULL
against	NULL
E-cadherin	NULL
,	NULL
with	NULL
more	NULL
prominent	NULL
surface	NULL
expression	NULL
along	NULL
the	NULL
lateral	NULL
aspect	NULL
of	NULL
the	NULL
cell	NULL
and	NULL
no	NULL
apical	NULL
surface	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
c	NULL
)	NULL
.	NULL

Less	NULL
intracellular	NULL
staining	NULL
was	NULL
evident	NULL
with	NULL
HLA	NULL
class	NULL
I	NULL
than	NULL
HLA	NULL
class	NULL
II	NULL
antibodies	NULL
.	NULL

The	NULL
staining	NULL
with	NULL
an	NULL
antibody	NULL
directed	NULL
against	NULL
the	NULL
P-glycopro-tein	NULL
(	NULL
MDR1	NULL
,	NULL
used	NULL
as	NULL
an	NULL
apical	NULL
marker	NULL
)	NULL
was	NULL
faint	NULL
but	NULL
restricted	NULL
to	NULL
the	NULL
apical	NULL
surface	NULL
.	NULL

To	NULL
confirm	NULL
that	NULL
the	NULL
distribution	NULL
of	NULL
the	NULL
various	NULL
proteins	NULL
by	NULL
confocal	NULL
microscopy	NULL
was	NULL
indeed	NULL
polarized	NULL
,	NULL
we	NULL
used	NULL
selective	NULL
cell	NULL
surface	NULL
biotinylation	NULL
to	NULL
independently	NULL
assess	NULL
and	NULL
quanti-tate	NULL
the	NULL
polarized	NULL
expression	NULL
of	NULL
HLA-DR	NULL
in	NULL
the	NULL
T84	NULL
transfectants	NULL
(	NULL
20	NULL
,	NULL
25	NULL
,	NULL
26	NULL
)	NULL
.	NULL

The	NULL
surface	NULL
of	NULL
intact	NULL
,	NULL
mature	NULL
monolayers	NULL
(	NULL
with	NULL
TER	NULL
values	NULL
>	NULL
1,000	NULL
ohm	NULL
ecm	NULL
?	NULL
)	NULL

were	NULL
labeled	NULL
apically	NULL
or	NULL
basolaterally	NULL
with	NULL
biotin	NULL
,	NULL
after	NULL
which	NULL
the	NULL
cells	NULL
were	NULL
lysed	NULL
,	NULL
im-munoprecipitated	NULL
using	NULL
antibodies	NULL
to	NULL
the	NULL
specific	NULL
proteins	NULL
,	NULL
analyzed	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
and	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
.	NULL

The	NULL
biotinylated	NULL
proteins	NULL
were	NULL
detected	NULL
using	NULL
peroxidase-conju-gated	NULL
streptavidin	NULL
and	NULL
chemiluminescence	NULL
.	NULL

As	NULL
seen	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
class	NULL
II	NULL
expression	NULL
was	NULL
only	NULL
seen	NULL
on	NULL
the	NULL
basolateral	NULL
surface	NULL
of	NULL
the	NULL
transfected	NULL
cells	NULL
,	NULL
whereas	NULL
none	NULL
was	NULL
seen	NULL
on	NULL
the	NULL
apical	NULL
surface	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
E-cadherin	NULL
(	NULL
a	NULL
well	NULL
characterized	NULL
marker	NULL
of	NULL
the	NULL
basolateral	NULL
surface	NULL
)	NULL
and	NULL
class	NULL
I	NULL
were	NULL
similarly	NULL
localized	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
MDR1a	NULL
could	NULL
only	NULL
be	NULL
detected	NULL
when	NULL
the	NULL
cells	NULL
were	NULL
biotinylated	NULL
apically	NULL
.	NULL

The	NULL
lack	NULL
of	NULL
surface	NULL
biotinylation	NULL
of	NULL
class	NULL
II	NULL
on	NULL
the	NULL
apical	NULL
surface	NULL
suggests	NULL
that	NULL
the	NULL
small	NULL
amount	NULL
of	NULL
staining	NULL
seen	NULL
on	NULL
the	NULL
apical	NULL
aspect	NULL
of	NULL
the	NULL
cells	NULL
by	NULL
confocal	NULL
microscopy	NULL
represented	NULL
intracellular	NULL
pools	NULL
of	NULL
the	NULL
protein	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
that	NULL
the	NULL
polarized	NULL
expression	NULL
of	NULL
class	NULL
II	NULL
in	NULL
T84	NULL
on	NULL
the	NULL
basolateral	NULL
surface	NULL
mimics	NULL
the	NULL
staining	NULL
pattern	NULL
for	NULL
class	NULL
II	NULL
seen	NULL
in	NULL
vivo	NULL
,	NULL
and	NULL
neither	NULL
requires	NULL
matrix	NULL
components	NULL
of	NULL
the	NULL
underlying	NULL
basement	NULL
membrane	NULL
nor	NULL
contact	NULL
with	NULL
adjacent	NULL
(	NULL
intraepithelial	NULL
lymphocytes	NULL
)	NULL
or	NULL
subja-cent	NULL
(	NULL
lamina	NULL
propia	NULL
lymphocytes	NULL
)	NULL
T	NULL
lymphocytes	NULL
.	NULL

Antigen	NULL
presentation	NULL
to	NULL
CD4*	NULL
T	NULL
lymphocytes	NULL
is	NULL
limited	NULL
to	NULL
the	NULL
basolateral	NULL
surface	NULL
,	NULL
but	NULL
antigen	NULL
processing	NULL
is	NULL
predominantly	NULL
initiated	NULL
from	NULL
the	NULL
apical	NULL
surface	NULL
in	NULL
T84	NULL
HLA-DR	NULL
transfec-	NULL
Figure	NULL
2	NULL
.	NULL

Selective	NULL
cell	NULL
surface	NULL
biotinylation	NULL
reveals	NULL
polarized	NULL
expression	NULL
of	NULL
HLA	NULL
class	NULL
II	NULL
molecules	NULL
at	NULL
the	NULL
basolateral	NULL
surface	NULL
.	NULL

T84	NULL
wild	NULL
type	NULL
,	NULL
T84	NULL
DRB1*0401	NULL
,	NULL
and	NULL
T84	NULL
DRB1*0401/CIITA	NULL
transfectants	NULL
were	NULL
plated	NULL
on	NULL
transwells	NULL
until	NULL
a	NULL
TER	NULL
>	NULL
1,000	NULL
ohm	NULL
em	NULL
was	NULL
ob-tained	NULL
,	NULL
and	NULL
then	NULL
biotinylated	NULL
on	NULL
their	NULL
apical	NULL
or	NULL
basolateral	NULL
surface	NULL
.	NULL

After	NULL
lysis	NULL
in	NULL
2.5	NULL
%	NULL
n-octylglucoside	NULL
,	NULL
immunoprecipitation	NULL
was	NULL
performed	NULL
using	NULL
mAb	NULL
against	NULL
the	NULL
proteins	NULL
listed	NULL
,	NULL
and	NULL
the	NULL
samples	NULL
were	NULL
fractionated	NULL
on	NULL
a	NULL
10	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
and	NULL
transferred	NULL
to	NULL
nitrocel-lulose	NULL
as	NULL
described	NULL
.	NULL

Streptavidin-HRP	NULL
and	NULL
the	NULL
chemiluminscent	NULL
substrate	NULL
ECL	NULL
were	NULL
used	NULL
to	NULL
detect	NULL
biotinylated	NULL
protein	NULL
.	NULL

E-cadherin	NULL
and	NULL
MDR	NULL
are	NULL
markers	NULL
of	NULL
basolateral	NULL
and	NULL
apical	NULL
membranes	NULL
,	NULL
respectively	NULL
.	NULL

A	NULL
%	NULL
1049	NULL
“	NULL
O	NULL
“	NULL
.X	NULL
42	NULL
q+	NULL
ot	NULL
Ap	NULL
Bl	NULL
Ap	NULL
BI	NULL
Ap	NULL
Bi	NULL
aum	NULL
«	NULL
ame	NULL
®	NULL
-	NULL
E-CADHERIN	NULL
<	NULL
me	NULL
gie	NULL
..	NULL
atis	NULL
-	NULL
CLASS	NULL
1	NULL
«	NULL
ous	NULL
a	NULL
«	NULL
zncmssu	NULL
«	NULL
-	NULL
«	NULL
»	NULL
an	NULL
MDR	NULL
tants	NULL
.	NULL

To	NULL
address	NULL
the	NULL
question	NULL
of	NULL
which	NULL
surface	NULL
or	NULL
surfaces	NULL
of	NULL
polarized	NULL
epithelial	NULL
cells	NULL
were	NULL
capable	NULL
of	NULL
stimulating	NULL
CD4®	NULL
T	NULL
cells	NULL
,	NULL
T84	NULL
HLA-DRB1*0401	NULL
transfectants	NULL
were	NULL
grown	NULL
on	NULL
semi-permeable	NULL
transwell	NULL
filters	NULL
and	NULL
tested	NULL
for	NULL
their	NULL
ability	NULL
to	NULL
stimulate	NULL
a	NULL
peptide-specific	NULL
,	NULL
HLA-DRB1*0401-restricted	NULL
T	NULL
cell	NULL
hybridoma	NULL
.	NULL

As	NULL
schematically	NULL
outlined	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
T84	NULL
cells	NULL
were	NULL
grown	NULL
with	NULL
their	NULL
apical	NULL
or	NULL
basolateral	NULL
surface	NULL
exposed	NULL
to	NULL
the	NULL
top	NULL
chamber	NULL
of	NULL
the	NULL
transwell	NULL
insert	NULL
,	NULL
and	NULL
cultured	NULL
to	NULL
allow	NULL
the	NULL
formation	NULL
of	NULL
a	NULL
monolayer	NULL
with	NULL
intact	NULL
tight	NULL
junctions	NULL
and	NULL
high	NULL
electrical	NULL
resistance	NULL
(	NULL
>	NULL
1,000	NULL
ohms	NULL
ecm	NULL
)	NULL
.	NULL

The	NULL
T84	NULL
DR4	NULL
cells	NULL
were	NULL
pulsed	NULL
for	NULL
1	NULL
h	NULL
with	NULL
peptide	NULL
,	NULL
after	NULL
which	NULL
T	NULL
cell	NULL
hybridomas	NULL
were	NULL
added	NULL
.	NULL

T	NULL
cells	NULL
were	NULL
always	NULL
added	NULL
to	NULL
the	NULL
top	NULL
chamber	NULL
to	NULL
maximize	NULL
IEC-T	NULL
cell	NULL
contact	NULL
.	NULL

Consistent	NULL
with	NULL
the	NULL
pattern	NULL
of	NULL
cell	NULL
surface	NULL
expression	NULL
of	NULL
class	NULL
II	NULL
antigens	NULL
observed	NULL
by	NULL
confocal	NULL
microscopy	NULL
and	NULL
selective	NULL
surface	NULL
biotinylation	NULL
,	NULL
only	NULL
the	NULL
basolateral	NULL
surface	NULL
of	NULL
the	NULL
T84	NULL
cells	NULL
could	NULL
present	NULL
peptide	NULL
antigen	NULL
to	NULL
T	NULL
lymphocytes	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

No	NULL
stimulation	NULL
was	NULL
seen	NULL
when	NULL
the	NULL
peptide	NULL
and	NULL
T	NULL
cells	NULL
were	NULL
added	NULL
to	NULL
the	NULL
apical	NULL
surface	NULL
of	NULL
the	NULL
T84	NULL
DR4	NULL
transfectants	NULL
.	NULL

The	NULL
stimulation	NULL
was	NULL
HLA-DR	NULL
allele-specific	NULL
,	NULL
as	NULL
the	NULL
T84	NULL
transfected	NULL
with	NULL
HLA-DRB1*1101	NULL
(	NULL
DRS	NULL
)	NULL
failed	NULL
to	NULL
stimulate	NULL
the	NULL
hybridoma	NULL
.	NULL

APCs	NULL
normally	NULL
must	NULL
process	NULL
intact	NULL
protein	NULL
to	NULL
generate	NULL
the	NULL
antigenic	NULL
peptides	NULL
that	NULL
bind	NULL
to	NULL
nascent	NULL
or	NULL
recycled	NULL
class	NULL
II	NULL
molecules	NULL
.	NULL

To	NULL
determine	NULL
which	NULL
surface	NULL
or	NULL
surfaces	NULL
of	NULL
the	NULL
entero-cyte	NULL
could	NULL
initiate	NULL
antigen	NULL
processing	NULL
of	NULL
an	NULL
intact	NULL
protein	NULL
via	NULL
HLA	NULL
class	NULL
II	NULL
molecules	NULL
,	NULL
we	NULL
exposed	NULL
either	NULL
the	NULL
apical	NULL
or	NULL
basolateral	NULL
surface	NULL
of	NULL
electrically	NULL
resistant	NULL
,	NULL
polarized	NULL
T84	NULL
DRB1	NULL
#	NULL
*0401	NULL
monolayers	NULL
to	NULL
an	NULL
intact	NULL
protein	NULL
antigen	NULL
(	NULL
TT	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
because	NULL
antigen	NULL
presentation	NULL
occurred	NULL
only	NULL
at	NULL
the	NULL
basolateral	NULL
surface	NULL
due	NULL
to	NULL
the	NULL
restricted	NULL
expression	NULL
of	NULL
HLA-DR	NULL
,	NULL
the	NULL
T84	NULL
transfectants	NULL
were	NULL
always	NULL
plated	NULL
``	NULL
bottoms	NULL
up	NULL
``	NULL
with	NULL
their	NULL
basolateral	NULL
surface	NULL
exposed	NULL
to	NULL
the	NULL
top	NULL
chamber	NULL
.	NULL

Hence	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
pulsed	NULL
with	NULL
intact	NULL
antigen	NULL
by	NULL
addition	NULL
to	NULL
the	NULL
bottom	NULL
(	NULL
apical	NULL
)	NULL
or	NULL
top	NULL
(	NULL
basolateral	NULL
)	NULL
chamber	NULL
.	NULL

Processing	NULL
was	NULL
quanti-tated	NULL
using	NULL
a	NULL
TT-specific	NULL
,	NULL
HLA-DRB1*0401-restricted	NULL
T	NULL
cell	NULL
hybridoma	NULL
,	NULL
added	NULL
after	NULL
antigen	NULL
pulsing	NULL
and	NULL
washing	NULL
.	NULL

As	NULL
shown	NULL
schematically	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
A	NULL
,	NULL
the	NULL
T	NULL
cells	NULL
were	NULL
always	NULL
added	NULL
to	NULL
the	NULL
top	NULL
chamber	NULL
where	NULL
basolateral	NULL
contact	NULL
(	NULL
and	NULL
antigen	NULL
presentation	NULL
)	NULL
occurs	NULL
.	NULL

Significant	NULL
processing	NULL
occurred	NULL
only	NULL
after	NULL
exposure	NULL
of	NULL
the	NULL
apical	NULL
surface	NULL
to	NULL
antigen	NULL
at	NULL
the	NULL
concentration	NULL
of	NULL
80	NULL
pg/ml	NULL
that	NULL
we	NULL
had	NULL
defined	NULL
as	NULL
the	NULL
optimal	NULL
concentration	NULL
from	NULL
previous	NULL
work	NULL
with	NULL
these	NULL
transfectants	NULL
(	NULL
14	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
)	NULL
.	NULL

To	NULL
ensure	NULL
that	NULL
the	NULL
results	NULL
obtained	NULL
were	NULL
not	NULL
restricted	NULL
to	NULL
a	NULL
single	NULL
concentration	NULL
of	NULL
antigen	NULL
,	NULL
we	NULL
performed	NULL
dose	NULL
response	NULL
curves	NULL
for	NULL
apical	NULL
and	NULL
basolateral	NULL
antigen	NULL
processing	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
B	NULL
,	NULL
minimal	NULL
to	NULL
no	NULL
processing	NULL
was	NULL
seen	NULL
when	NULL
intact	NULL
antigen	NULL
Polarity	NULL
and	NULL
HLA	NULL
Class	NULL
II	NULL
__	NULL
795	NULL
Basolateral	NULL
Figure	NULL
3	NULL
.	NULL

HLA-DR-restricted	NULL
peptide	NULL
presentation	NULL
occurs	NULL
only	NULL
at	NULL
the	NULL
basolateral	NULL
surface	NULL
of	NULL
T84	NULL
cells	NULL
.	NULL

(	NULL
Top	NULL
)	NULL
Schematic	NULL
view	NULL
of	NULL
transwell	NULL
antigen	NULL
presentation	NULL
assay	NULL
.	NULL

160	NULL
Apical	NULL
140	NULL
+	NULL
120	NULL
4+	NULL
100	NULL
4	NULL
60	NULL
+	NULL
HT-2	NULL
Proliferation	NULL
(	NULL
cpm	NULL
x	NULL
10°	NULL
)	NULL
-	NULL
TS4DR4	NULL
TB4DR4	NULL
T8B4DRS	NULL
OuM	NULL
10uM	NULL
__	NULL
10uM	NULL
OuM	NULL
[	NULL
HSA	NULL
peptide	NULL
]	NULL
was	NULL
added	NULL
to	NULL
the	NULL
basolateral	NULL
surface	NULL
over	NULL
a	NULL
wide	NULL
range	NULL
of	NULL
TT	NULL
concentrations	NULL
.	NULL

As	NULL
with	NULL
the	NULL
peptide-specific	NULL
presentation	NULL
seen	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
no	NULL
class	NULL
II-mediated	NULL
antigen	NULL
presentation	NULL
of	NULL
processed	NULL
antigen	NULL
was	NULL
seen	NULL
at	NULL
the	NULL
apical	NULL
surface	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Note	NULL
that	NULL
these	NULL
observations	NULL
are	NULL
consistent	NULL
with	NULL
our	NULL
previous	NULL
results	NULL
on	NULL
96-well	NULL
plates	NULL
(	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
transwell	NULL
system	NULL
described	NULL
here	NULL
)	NULL
,	NULL
demonstrating	NULL
that	NULL
T84	NULL
DR4	NULL
are	NULL
capable	NULL
of	NULL
limited	NULL
class	NULL
II	NULL
processing	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
Ii	NULL
and	NULL
HLA-DM	NULL
(	NULL
14	NULL
)	NULL
.	NULL

To	NULL
ensure	NULL
that	NULL
the	NULL
differences	NULL
observed	NULL
did	NULL
not	NULL
simply	NULL
reflect	NULL
an	NULL
inability	NULL
of	NULL
the	NULL
basolateral	NULL
surface	NULL
of	NULL
the	NULL
T84	NULL
DR4	NULL
cells	NULL
to	NULL
internalize	NULL
protein	NULL
antigen	NULL
,	NULL
we	NULL
directly	NULL
measured	NULL
the	NULL
uptake	NULL
of	NULL
intact	NULL
HRP	NULL
by	NULL
both	NULL
the	NULL
apical	NULL
and	NULL
basolateral	NULL
surface	NULL
at	NULL
various	NULL
time	NULL
points	NULL
including	NULL
15	NULL
,	NULL
30	NULL
,	NULL
and	NULL
60	NULL
min	NULL
.	NULL

At	NULL
all	NULL
time	NULL
points	NULL
tested	NULL
in	NULL
several	NULL
independent	NULL
experiments	NULL
,	NULL
the	NULL
basolateral	NULL
surface	NULL
was	NULL
more	NULL
efficient	NULL
at	NULL
internalizing	NULL
HRP	NULL
than	NULL
the	NULL
apical	NULL
surface	NULL
under	NULL
identical	NULL
conditions	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Overexpression	NULL
of	NULL
the	NULL
class	NULL
II	NULL
transactivator	NULL
,	NULL
CIITA	NULL
,	NULL
results	NULL
in	NULL
efficient	NULL
antigen	NULL
processing	NULL
without	NULL
affecting	NULL
the	NULL
barrier	NULL
function	NULL
of	NULL
polarized	NULL
T84	NULL
cells	NULL
.	NULL

We	NULL
have	NULL
recently	NULL
shown	NULL
that	NULL
efficient	NULL
antigen	NULL
processing	NULL
by	NULL
T84	NULL
cells	NULL
requires	NULL
the	NULL
expression	NULL
of	NULL
not	NULL
only	NULL
class	NULL
II	NULL
antigens	NULL
and	NULL
cellular	NULL
proteases	NULL
,	NULL
but	NULL
also	NULL
the	NULL
Ii	NULL
and	NULL
the	NULL
HLA-DM	NULL
heterodimer	NULL
(	NULL
14	NULL
)	NULL
.	NULL

The	NULL
role	NULL
of	NULL
these	NULL
molecules	NULL
in	NULL
class	NULL
II	NULL
biosynthesis	NULL
and	NULL
antigen	NULL
processing	NULL
has	NULL
been	NULL
extensively	NULL
reviewed	NULL
(	NULL
11	NULL
,	NULL
12	NULL
)	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
both	NULL
Ti	NULL
and	NULL
HLA-DM	NULL
is	NULL
induced	NULL
by	NULL
y-IFN	NULL
in	NULL
T84	NULL
,	NULL
likely	NULL
mediated	NULL
by	NULL
the	NULL
transcriptional	NULL
activation	NULL
of	NULL
these	NULL
genes	NULL
by	NULL
the	NULL
CIITA	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
which	NULL
is	NULL
also	NULL
induced	NULL
by	NULL
y-IFN	NULL
(	NULL
27	NULL
)	NULL
.	NULL

796	NULL
_-	NULL
Hershberg	NULL
et	NULL
al	NULL
.	NULL

Basolateral	NULL
T84DR4	NULL
T8S4DR4	NULL
T84DRS	NULL
10uM	NULL
T84	NULL
cells	NULL
are	NULL
plated	NULL
on	NULL
upright	NULL
transwell	NULL
filters	NULL
(	NULL
3.0	NULL
u	NULL
pore	NULL
size	NULL
)	NULL
,	NULL
exposing	NULL
the	NULL
apical	NULL
surface	NULL
to	NULL
the	NULL
top	NULL
chamber	NULL
,	NULL
or	NULL
on	NULL
upside-down	NULL
filters	NULL
that	NULL
are	NULL
subsequently	NULL
inverted	NULL
,	NULL
exposing	NULL
the	NULL
basolateral	NULL
surface	NULL
to	NULL
the	NULL
top	NULL
chamber	NULL
.	NULL

T	NULL
cells	NULL
are	NULL
always	NULL
added	NULL
to	NULL
the	NULL
top	NULL
chamber	NULL
to	NULL
maximize	NULL
T	NULL
cell-T84	NULL
contact	NULL
.	NULL

(	NULL
Bottom	NULL
)	NULL
T84	NULL
HLA-DRB1	NULL
#	NULL
*0401	NULL
transfectants	NULL
plated	NULL
in	NULL
the	NULL
apical	NULL
or	NULL
basolateral	NULL
orientation	NULL
were	NULL
co-cultured	NULL
with	NULL
HSA	NULL
-specific	NULL
,	NULL
HLA-DRB1*0401-restricted	NULL
T	NULL
cell	NULL
hybridoma	NULL
cells	NULL
for	NULL
24	NULL
h	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
10	NULL
mM	NULL
of	NULL
the	NULL
HSA	NULL
peptide	NULL
for	NULL
which	NULL
the	NULL
hybridomas	NULL
are	NULL
specific	NULL
.	NULL

T84	NULL
transfectants	NULL
expressing	NULL
similar	NULL
levels	NULL
of	NULL
the	NULL
HLA-DRB1*1101	NULL
(	NULL
DR5	NULL
)	NULL
allele	NULL
were	NULL
used	NULL
as	NULL
a	NULL
negative	NULL
control	NULL
.	NULL

IL-2	NULL
production	NULL
of	NULL
the	NULL
hybridomas	NULL
was	NULL
quanti-tated	NULL
using	NULL
the	NULL
supernatant	NULL
from	NULL
the	NULL
top	NULL
chamber	NULL
by	NULL
[	NULL
°H	NULL
]	NULL
thymidine	NULL
uptake	NULL
(	NULL
cpm	NULL
)	NULL
of	NULL
the	NULL
IL-2/IL-4	NULL
dependent	NULL
T	NULL
cell	NULL
line	NULL
HT-2	NULL
,	NULL
as	NULL
described	NULL
in	NULL
Methods	NULL
.	NULL

10uM	NULL
T84	NULL
DRB1*0401	NULL
transfectants	NULL
superinfected	NULL
with	NULL
a	NULL
retrovirus	NULL
directing	NULL
the	NULL
overexpression	NULL
of	NULL
CIITA	NULL
resulted	NULL
in	NULL
class	NULL
II	NULL
antigen	NULL
processing	NULL
and	NULL
presentation	NULL
to	NULL
CD4*	NULL
T	NULL
cells	NULL
similar	NULL
to	NULL
that	NULL
seen	NULL
after	NULL
treatment	NULL
of	NULL
the	NULL
cells	NULL
with	NULL
y-IFN	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
A	NULL
)	NULL
.	NULL

The	NULL
induced	NULL
expression	NULL
of	NULL
Ii	NULL
,	NULL
HLA-DMa	NULL
«	NULL
and	NULL
HLA-DMB	NULL
was	NULL
confirmed	NULL
in	NULL
the	NULL
T84	NULL
CIITA	NULL
transfectants	NULL
by	NULL
immunoblotting	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
B	NULL
)	NULL
.	NULL

As	NULL
previously	NULL
shown	NULL
(	NULL
14	NULL
)	NULL
and	NULL
confirmed	NULL
here	NULL
,	NULL
the	NULL
wild-type	NULL
T84	NULL
cells	NULL
do	NULL
not	NULL
express	NULL
Ii	NULL
,	NULL
HLA-DMa	NULL
«	NULL
,	NULL
or	NULL
HLA-DMB	NULL
.	NULL

We	NULL
also	NULL
used	NULL
an	NULL
HLA-DR1-specific	NULL
mAb	NULL
and	NULL
flow	NULL
cytometry	NULL
to	NULL
demonstrate	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
endogenous	NULL
HLA-DRB1	NULL
#	NULL
*0101	NULL
allele	NULL
induced	NULL
by	NULL
the	NULL
overexpression	NULL
of	NULL
CIITA	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
stimulating	NULL
antigen	NULL
processing	NULL
by	NULL
T84	NULL
cells	NULL
,	NULL
y-IFN	NULL
treatment	NULL
has	NULL
been	NULL
observed	NULL
to	NULL
elicit	NULL
a	NULL
profound	NULL
and	NULL
relatively	NULL
rapid	NULL
decrease	NULL
in	NULL
TER	NULL
in	NULL
T84	NULL
monolayers	NULL
without	NULL
an	NULL
immediate	NULL
alteration	NULL
in	NULL
cell	NULL
morphology	NULL
or	NULL
integrity	NULL
of	NULL
the	NULL
monolayer	NULL
(	NULL
18	NULL
)	NULL
.	NULL

This	NULL
alteration	NULL
in	NULL
barrier	NULL
function	NULL
after	NULL
y-IFN	NULL
treatment	NULL
would	NULL
limit	NULL
the	NULL
ability	NULL
to	NULL
selectively	NULL
expose	NULL
one	NULL
surface	NULL
of	NULL
the	NULL
cell	NULL
to	NULL
intact	NULL
antigen	NULL
and	NULL
to	NULL
independently	NULL
study	NULL
the	NULL
polarity	NULL
of	NULL
antigen	NULL
processing	NULL
and	NULL
presentation	NULL
.	NULL

Surprisingly	NULL
,	NULL
we	NULL
observed	NULL
that	NULL
the	NULL
T84	NULL
HLA-DRB1	NULL
#	NULL
*0401	NULL
transfectants	NULL
overexpressing	NULL
CIITA	NULL
were	NULL
able	NULL
to	NULL
maintain	NULL
a	NULL
high	NULL
TER	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
C	NULL
)	NULL
,	NULL
despite	NULL
showing	NULL
many	NULL
of	NULL
the	NULL
characteristics	NULL
of	NULL
transfectants	NULL
treated	NULL
with	NULL
y-IFN	NULL
with	NULL
regards	NULL
to	NULL
class	NULL
II	NULL
antigen	NULL
processing	NULL
.	NULL

Treatment	NULL
of	NULL
the	NULL
T84	NULL
CIITA	NULL
transfectants	NULL
with	NULL
y-IFN	NULL
resulted	NULL
in	NULL
the	NULL
characteristic	NULL
decline	NULL
in	NULL
TER	NULL
seen	NULL
in	NULL
the	NULL
wild-type	NULL
T84	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
C	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
directed	NULL
overex-	NULL
Basolateral	NULL
BOOUG	NULL
cnl	NULL
sug	NULL
Apical	NULL
70000	NULL
60000	NULL
50000	NULL
40000	NULL
30000	NULL
HT-2	NULL
Proliferation	NULL
(	NULL
cpm	NULL
)	NULL
20000	NULL
10000	NULL
[	NULL
TT	NULL
]	NULL
,	NULL
ug/ml	NULL
250000	NULL
€	NULL
200000	NULL
+	NULL
a	NULL
S	NULL
5	NULL
B	NULL
®	NULL
-	NULL
150000	NULL
$	NULL
C	NULL
€	NULL
_	NULL
4100000	NULL
+	NULL
a	NULL
iI	NULL
50000	NULL
0	NULL
20	NULL
40	NULL
60	NULL
80	NULL
100	NULL
120	NULL
140	NULL
[	NULL
TT	NULL
]	NULL
,	NULL
pg/ml	NULL
pression	NULL
of	NULL
CIITA	NULL
was	NULL
not	NULL
``	NULL
dominant	NULL
``	NULL
to	NULL
the	NULL
effects	NULL
seen	NULL
with	NULL
y-IFN	NULL
in	NULL
altering	NULL
barrier	NULL
function	NULL
.	NULL

The	NULL
pattern	NULL
of	NULL
TER	NULL
elevation	NULL
after	NULL
plating	NULL
of	NULL
the	NULL
cells	NULL
on	NULL
transwells	NULL
and	NULL
the	NULL
kinetics	NULL
and	NULL
character	NULL
of	NULL
the	NULL
response	NULL
to	NULL
y-IFN	NULL
were	NULL
identical	NULL
in	NULL
the	NULL
wild	NULL
Basolateral	NULL
Figure	NULL
4	NULL
.	NULL

Class	NULL
II	NULL
antigen	NULL
processing	NULL
of	NULL
intact	NULL
tetanus	NULL
toxoid	NULL
in	NULL
T84	NULL
HLA-DR	NULL
trans-fectant	NULL
is	NULL
markedly	NULL
more	NULL
efficient	NULL
after	NULL
exposure	NULL
of	NULL
intact	NULL
antigen	NULL
from	NULL
the	NULL
apical	NULL
than	NULL
from	NULL
the	NULL
basolateral	NULL
surface	NULL
.	NULL

A	NULL
.	NULL

(	NULL
Top	NULL
)	NULL
Schematic	NULL
view	NULL
of	NULL
transwell	NULL
antigen	NULL
processing	NULL
assay	NULL
.	NULL

Because	NULL
HLA-DR	NULL
expression	NULL
and	NULL
antigen	NULL
presentation	NULL
is	NULL
restricted	NULL
to	NULL
the	NULL
basolateral	NULL
surface	NULL
(	NULL
Figs	NULL
.	NULL

1-3	NULL
)	NULL
,	NULL
the	NULL
T84	NULL
HLA-DR4	NULL
transfectants	NULL
are	NULL
plated	NULL
with	NULL
their	NULL
basolateral	NULL
surface	NULL
exposed	NULL
to	NULL
the	NULL
top	NULL
chamber	NULL
.	NULL

The	NULL
polarized	NULL
,	NULL
electrically	NULL
resistant	NULL
(	NULL
>	NULL
1,000	NULL
ohm	NULL
em	NULL
?	NULL
)	NULL

monolayers	NULL
were	NULL
then	NULL
pulsed	NULL
for	NULL
4	NULL
h	NULL
with	NULL
antigen	NULL
from	NULL
the	NULL
apical	NULL
surface	NULL
(	NULL
bottom	NULL
chamber	NULL
)	NULL
or	NULL
basolateral	NULL
surface	NULL
(	NULL
top	NULL
chamber	NULL
)	NULL
,	NULL
after	NULL
which	NULL
the	NULL
antigen	NULL
was	NULL
removed	NULL
and	NULL
T	NULL
cells	NULL
were	NULL
added	NULL
always	NULL
to	NULL
the	NULL
top	NULL
chamber	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

(	NULL
Bottom	NULL
)	NULL
IL-2	NULL
production	NULL
from	NULL
a	NULL
TT	NULL
-specific	NULL
,	NULL
HLA-DRB1*0401-restricted	NULL
T	NULL
cell	NULL
hybridoma	NULL
after	NULL
an	NULL
80	NULL
pg/ml	NULL
TT	NULL
pulse	NULL
,	NULL
wash	NULL
,	NULL
and	NULL
20-h	NULL
co-cultivation	NULL
of	NULL
the	NULL
T	NULL
cells	NULL
with	NULL
the	NULL
T84	NULL
monolayers	NULL
.	NULL

B.	NULL
Antigen	NULL
dose-response	NULL
curve	NULL
after	NULL
exposure	NULL
to	NULL
the	NULL
apical	NULL
(	NULL
open	NULL
triangles	NULL
)	NULL
or	NULL
basolateral	NULL
surface	NULL
(	NULL
open	NULL
squares	NULL
)	NULL
as	NULL
outlined	NULL
above	NULL
.	NULL

-A-	NULL
Apical	NULL
-B-	NULL
Basolateral	NULL
type	NULL
T84	NULL
cells	NULL
and	NULL
the	NULL
CIITA	NULL
transfectants	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
as	NULL
seen	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
there	NULL
was	NULL
no	NULL
discernible	NULL
difference	NULL
in	NULL
morphology	NULL
,	NULL
ZO-1	NULL
staining	NULL
,	NULL
or	NULL
class	NULL
II	NULL
localization	NULL
in	NULL
the	NULL
CIITA	NULL
transfectants	NULL
compared	NULL
to	NULL
the	NULL
HLA-DR	NULL
transfectants	NULL
.	NULL

Polarity	NULL
and	NULL
HLA	NULL
Class	NULL
II	NULL
_	NULL
797	NULL
A	NULL
_	NULL
100-	NULL
B	NULL
«	NULL
&	NULL
&	NULL
G	NULL
2	NULL
so	NULL
|	NULL
£	NULL
4	NULL
-	NULL
S	NULL
2	NULL
80	NULL
$	NULL
a	NULL
&	NULL
&	NULL
8	NULL
7	NULL
p41-60-7	NULL
f	NULL
]	NULL
5	NULL
Invariant	NULL
Chain	NULL
-	NULL
P35-	NULL
>	NULL
uw	NULL
,	NULL
@	NULL
ie	NULL
Fo	NULL
7	NULL
p33	NULL
$	NULL
407	NULL
sy	NULL
S	NULL
|	NULL
HLA-DMa	NULL
Wk	NULL
¥	NULL
#	NULL
m	NULL
20-r=	NULL
-	NULL
HLA-DMB	NULL
a	NULL
.	NULL
'	NULL

0	NULL
[	NULL
TT	NULL
]	NULL
,	NULL
pg/ml	NULL
C	NULL
3000-	NULL
D	NULL
-	NULL
€	NULL
C	NULL
&	NULL
2	NULL
L	NULL
2000-7	NULL
s	NULL
5	NULL
©	NULL
a	NULL
-	NULL
8	NULL
C	NULL
&	NULL
B	NULL
-	NULL
1000-7	NULL
5	NULL
®	NULL
A	NULL
-	NULL
<	NULL
0	NULL
I	NULL
I	NULL
I	NULL
I	NULL
T	NULL
T	NULL
T	NULL
0	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
No	NULL
HRP	NULL
Triton	NULL
X	NULL
No	NULL
T	NULL
cells	NULL
-	NULL
Tcells+Ag	NULL
Days	NULL
Figure	NULL
5	NULL
.	NULL

The	NULL
overexpression	NULL
of	NULL
the	NULL
class	NULL
II	NULL
transactivator	NULL
CIITA	NULL
in	NULL
T84	NULL
HLA-DR	NULL
transfectants	NULL
results	NULL
in	NULL
efficient	NULL
antigen	NULL
processing	NULL
without	NULL
affecting	NULL
barrier	NULL
function	NULL
.	NULL

(	NULL
A	NULL
)	NULL
IL-2	NULL
production	NULL
by	NULL
the	NULL
TT	NULL
-specific	NULL
,	NULL
HLA-DRB1*0401-specific	NULL
hybridoma	NULL
stimulated	NULL
by	NULL
T84	NULL
HLA-DRB1*0401	NULL
transfectants	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
right	NULL
)	NULL
or	NULL
absence	NULL
(	NULL
lef	NULL
?	NULL
)	NULL

of	NULL
80	NULL
g/ml	NULL
TT	NULL
.	NULL

Assays	NULL
were	NULL
performed	NULL
on	NULL
96-well	NULL
flat	NULL
bottom	NULL
plates	NULL
(	NULL
not	NULL
on	NULL
transwells	NULL
)	NULL
as	NULL
described	NULL
previously	NULL
.	NULL

T84	NULL
cells	NULL
used	NULL
were	NULL
T84	NULL
HLA-DRB1*0401	NULL
(	NULL
stippled	NULL
bars	NULL
)	NULL
,	NULL
T84	NULL
HLA-DRB1*0401	NULL
pulsed	NULL
with	NULL
y-IFN	NULL
for	NULL
48	NULL
h	NULL
before	NULL
addition	NULL
of	NULL
TT	NULL
(	NULL
striped	NULL
bars	NULL
)	NULL
,	NULL
and	NULL
T84	NULL
HLA-DRB1*0401/CIITA	NULL
transfectants	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
y-IFN	NULL
(	NULL
filled	NULL
bars	NULL
)	NULL
(	NULL
B	NULL
)	NULL
Immunoblot	NULL
analysis	NULL
using	NULL
antibodies	NULL
specific	NULL
for	NULL
Ii	NULL
,	NULL
HLA-DMa	NULL
,	NULL
or	NULL
HLA-DMB	NULL
in	NULL
the	NULL
cells	NULL
listed	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Overexpression	NULL
of	NULL
CIITA	NULL
does	NULL
not	NULL
impair	NULL
the	NULL
ability	NULL
of	NULL
T84	NULL
cells	NULL
to	NULL
develop	NULL
a	NULL
high	NULL
TER	NULL
.	NULL

Both	NULL
curves	NULL
represent	NULL
TER	NULL
data	NULL
from	NULL
T84	NULL
cells	NULL
transfected	NULL
with	NULL
and	NULL
expressing	NULL
CIITA	NULL
.	NULL

Media	NULL
from	NULL
both	NULL
the	NULL
top	NULL
and	NULL
bottom	NULL
chambers	NULL
were	NULL
changed	NULL
daily	NULL
with	NULL
(	NULL
closed	NULL
circles	NULL
)	NULL
or	NULL
without	NULL
(	NULL
open	NULL
circles	NULL
)	NULL
the	NULL
addition	NULL
of	NULL
500	NULL
/ml	NULL
y-IFN	NULL
to	NULL
the	NULL
basolateral	NULL
surface	NULL
of	NULL
the	NULL
cell	NULL
.	NULL

(	NULL
D	NULL
)	NULL
Overexpression	NULL
of	NULL
CIITA	NULL
does	NULL
not	NULL
result	NULL
in	NULL
the	NULL
paracellular	NULL
transport	NULL
of	NULL
proteins	NULL
across	NULL
the	NULL
T84	NULL
monolayer	NULL
.	NULL

Bulk	NULL
protein	NULL
transport	NULL
was	NULL
assessed	NULL
using	NULL
intact	NULL
HRP	NULL
as	NULL
described	NULL
.	NULL

To	NULL
ensure	NULL
transport	NULL
was	NULL
not	NULL
affected	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
T	NULL
lymphocytes	NULL
to	NULL
the	NULL
monolayer	NULL
during	NULL
the	NULL
processing	NULL
assays	NULL
,	NULL
the	NULL
HRP	NULL
assays	NULL
were	NULL
done	NULL
immediately	NULL
after	NULL
co-cultivation	NULL
of	NULL
the	NULL
T84	NULL
monolayers	NULL
with	NULL
100	NULL
x	NULL
10°	NULL
T	NULL
cells	NULL
for	NULL
24	NULL
h	NULL
in	NULL
the	NULL
ab-	NULL
sence	NULL
(	NULL
T	NULL
cells	NULL
)	NULL
or	NULL
presence	NULL
(	NULL
T	NULL
cells	NULL
+	NULL
ag	NULL
)	NULL
of	NULL
antigen	NULL
.	NULL

The	NULL
respective	NULL
cells	NULL
used	NULL
were	NULL
as	NULL
labeled	NULL
in	NULL
A	NULL
.	NULL

The	NULL
intact	NULL
barrier	NULL
function	NULL
of	NULL
the	NULL
T84	NULL
cells	NULL
overexpressing	NULL
CIITA	NULL
was	NULL
further	NULL
verified	NULL
by	NULL
their	NULL
inability	NULL
to	NULL
allow	NULL
passage	NULL
of	NULL
intact	NULL
HRP	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
D	NULL
)	NULL
.	NULL

The	NULL
addition	NULL
and	NULL
24-h	NULL
co-culture	NULL
of	NULL
antigen	NULL
and	NULL
antigen-specific	NULL
,	NULL
HLA-DRB1*0401-restricted	NULL
T	NULL
cell	NULL
hybridomas	NULL
to	NULL
either	NULL
the	NULL
T84	NULL
DR4	NULL
or	NULL
T84	NULL
DR4	NULL
CHTA	NULL
transfectants	NULL
did	NULL
not	NULL
result	NULL
in	NULL
any	NULL
transport	NULL
of	NULL
HRP	NULL
across	NULL
the	NULL
monolayer	NULL
(	NULL
5	NULL
D	NULL
,	NULL
``	NULL
T	NULL
cells	NULL
+	NULL
Ag	NULL
``	NULL
)	NULL
,	NULL
demonstrating	NULL
that	NULL
the	NULL
monolayers	NULL
restricted	NULL
passage	NULL
of	NULL
protein	NULL
during	NULL
the	NULL
typical	NULL
course	NULL
of	NULL
the	NULL
antigen-processing	NULL
experiments	NULL
.	NULL

Hence	NULL
,	NULL
overexpression	NULL
of	NULL
CIITA	NULL
resulted	NULL
in	NULL
efficient	NULL
HLA	NULL
class	NULL
II	NULL
antigen	NULL
processing	NULL
,	NULL
but	NULL
had	NULL
no	NULL
apparent	NULL
effect	NULL
on	NULL
barrier	NULL
function	NULL
in	NULL
T84	NULL
cells	NULL
.	NULL

These	NULL
results	NULL
demonstrate	NULL
that	NULL
y-IFN-induced	NULL
changes	NULL
in	NULL
APC	NULL
activity	NULL
can	NULL
be	NULL
dissociated	NULL
at	NULL
a	NULL
molecular	NULL
level	NULL
from	NULL
the	NULL
barrier-disrupting	NULL
activity	NULL
.	NULL

The	NULL
overexpression	NULL
of	NULL
CIITA	NULL
facilitates	NULL
HLA	NULL
class	NULL
II	NULL
antigen	NULL
processing	NULL
from	NULL
the	NULL
basolateral	NULL
surface	NULL
of	NULL
polarized	NULL
T84	NULL
monolayers	NULL
.	NULL

Next	NULL
we	NULL
assessed	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
T84	NULL
HLA-DRB1	NULL
#	NULL
*0401/CIHITA	NULL
transfectants	NULL
to	NULL
process	NULL
intact	NULL
protein	NULL
antigen	NULL
in	NULL
the	NULL
polarized	NULL
processing	NULL
assays	NULL
.	NULL

Note	NULL
that	NULL
increased	NULL
class	NULL
II	NULL
expression	NULL
in	NULL
the	NULL
CIITA	NULL
transfectants	NULL
(	NULL
compared	NULL
to	NULL
798	NULL
_-	NULL
Hershberg	NULL
et	NULL
al	NULL
.	NULL

the	NULL
T84	NULL
DR4	NULL
transfectants	NULL
alone	NULL
)	NULL
corresponds	NULL
to	NULL
that	NULL
from	NULL
the	NULL
endogenous	NULL
HLA-DRB1	NULL
#	NULL
*0101	NULL
allele	NULL
and	NULL
does	NULL
not	NULL
interfere	NULL
with	NULL
the	NULL
functional	NULL
studies	NULL
detailed	NULL
using	NULL
T	NULL
cells	NULL
that	NULL
are	NULL
restricted	NULL
to	NULL
the	NULL
transfected	NULL
HLA-DRB1*0401	NULL
allele	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
restricted	NULL
ability	NULL
of	NULL
the	NULL
HLA-DR	NULL
transfectants	NULL
to	NULL
initiate	NULL
processing	NULL
of	NULL
intact	NULL
TT	NULL
only	NULL
at	NULL
the	NULL
apical	NULL
surface	NULL
,	NULL
the	NULL
T84	NULL
HLA-DR4/CIITA	NULL
transfectants	NULL
could	NULL
initiate	NULL
processing	NULL
from	NULL
either	NULL
the	NULL
apical	NULL
or	NULL
basolateral	NULL
surface	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

The	NULL
antigen	NULL
dose	NULL
response	NULL
curves	NULL
done	NULL
under	NULL
identical	NULL
conditions	NULL
consistently	NULL
reveal	NULL
that	NULL
the	NULL
apical	NULL
processing	NULL
in	NULL
the	NULL
DR4/	NULL
CIITA	NULL
transfectants	NULL
is	NULL
more	NULL
efficient	NULL
at	NULL
low	NULL
antigen	NULL
doses	NULL
than	NULL
the	NULL
basolateral	NULL
processing	NULL
in	NULL
the	NULL
DR4/CIHITA	NULL
transfec-tants	NULL
,	NULL
or	NULL
the	NULL
apical	NULL
processing	NULL
in	NULL
the	NULL
DR4	NULL
transfectants	NULL
alone	NULL
(	NULL
Figs	NULL
.	NULL

4	NULL
B	NULL
and	NULL
6	NULL
)	NULL
.	NULL

The	NULL
data	NULL
indicate	NULL
that	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
CIITA	NULL
expression	NULL
(	NULL
mirroring	NULL
the	NULL
response	NULL
of	NULL
y-IFN	NULL
facilitating	NULL
efficient	NULL
antigen	NULL
processing	NULL
)	NULL
,	NULL
the	NULL
highly	NULL
restricted	NULL
polar	NULL
initiation	NULL
of	NULL
processing	NULL
is	NULL
no	NULL
longer	NULL
evident	NULL
,	NULL
and	NULL
both	NULL
polar	NULL
surfaces	NULL
can	NULL
initiate	NULL
antigen	NULL
processing	NULL
.	NULL

In	NULL
both	NULL
instances	NULL
,	NULL
the	NULL
presentation	NULL
to	NULL
CD4*	NULL
T	NULL
cells	NULL
remains	NULL
restricted	NULL
to	NULL
the	NULL
basolateral	NULL
surface	NULL
of	NULL
the	NULL
cell	NULL
.	NULL

300000	NULL
Figure	NULL
6	NULL
.	NULL

Expression	NULL
of	NULL
CITA	NULL
in	NULL
the	NULL
T84	NULL
250000	NULL
--	NULL
200000	NULL
--	NULL
150000	NULL
+	NULL
100000	NULL
+	NULL
HT-2	NULL
Proliferation	NULL
(	NULL
cpm	NULL
)	NULL
50000	NULL
1	NULL
|	NULL
|	NULL
A	NULL
1	NULL
1	NULL
:	NULL
i	NULL
i	NULL
t	NULL
t	NULL
i	NULL
1	NULL
t	NULL
0	NULL
20	NULL
40	NULL
60	NULL
80	NULL
100	NULL
120	NULL
140	NULL
[	NULL
TT	NULL
]	NULL
,	NULL
pg/ml	NULL
Class	NULL
II	NULL
processing	NULL
initiated	NULL
from	NULL
both	NULL
the	NULL
apical	NULL
and	NULL
basolateral	NULL
surface	NULL
requires	NULL
endosomal	NULL
acidification	NULL
but	NULL
only	NULL
the	NULL
apical	NULL
processing	NULL
is	NULL
inhibited	NULL
by	NULL
disruption	NULL
of	NULL
the	NULL
actin-based	NULL
cytoskeleton	NULL
.	NULL

We	NULL
next	NULL
compared	NULL
the	NULL
sensitivity	NULL
of	NULL
the	NULL
apical	NULL
processing	NULL
in	NULL
the	NULL
T84	NULL
DR4	NULL
transfectants	NULL
and	NULL
the	NULL
apical	NULL
and	NULL
basolateral	NULL
processing	NULL
in	NULL
the	NULL
T84	NULL
DR4/CIITA	NULL
transfectants	NULL
to	NULL
several	NULL
drugs	NULL
known	NULL
to	NULL
inhibit	NULL
endocytosis	NULL
or	NULL
intracellular	NULL
trafficking	NULL
events	NULL
involved	NULL
in	NULL
class	NULL
II	NULL
processing	NULL
to	NULL
investigate	NULL
the	NULL
class	NULL
II	NULL
pathways	NULL
from	NULL
the	NULL
distinct	NULL
polarized	NULL
surfaces	NULL
.	NULL

Based	NULL
on	NULL
the	NULL
data	NULL
obtained	NULL
from	NULL
the	NULL
TT	NULL
dose	NULL
response	NULL
curves	NULL
,	NULL
all	NULL
drug	NULL
inhibition	NULL
experiments	NULL
were	NULL
performed	NULL
at	NULL
a	NULL
TT	NULL
concentration	NULL
of	NULL
80	NULL
ug/ml	NULL
.	NULL

The	NULL
drug	NULL
concentrations	NULL
used	NULL
were	NULL
determined	NULL
to	NULL
be	NULL
noncytopathic	NULL
by	NULL
light	NULL
microscopy	NULL
,	NULL
and	NULL
TER	NULL
was	NULL
checked	NULL
at	NULL
the	NULL
conclusion	NULL
of	NULL
the	NULL
experiment	NULL
,	NULL
and	NULL
although	NULL
re-duced	NULL
,	NULL
was	NULL
found	NULL
to	NULL
be	NULL
>	NULL
300	NULL
ohms	NULL
em	NULL
at	NULL
the	NULL
concentrations	NULL
and	NULL
exposure	NULL
times	NULL
indicated	NULL
.	NULL

Cytochalasin	NULL
D	NULL
interferes	NULL
with	NULL
the	NULL
function	NULL
of	NULL
actin-con-taining	NULL
microfilaments	NULL
and	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
selectively	NULL
inhibit	NULL
apical	NULL
endocytosis	NULL
in	NULL
Madine-Darby	NULL
canine	NULL
kidney	NULL
(	NULL
MDCK	NULL
)	NULL
cells	NULL
(	NULL
28	NULL
,	NULL
29	NULL
)	NULL
.	NULL

Analogously	NULL
,	NULL
cytochalasin	NULL
D	NULL
selectively	NULL
inhibited	NULL
the	NULL
antigen	NULL
processing	NULL
of	NULL
apically	NULL
added	NULL
antigen	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
processing	NULL
from	NULL
the	NULL
basolateral	NULL
surface	NULL
was	NULL
unaffected	NULL
by	NULL
cytochalasin	NULL
D.	NULL
The	NULL
macrolide	NULL
antibiotic	NULL
bafilomycin	NULL
A1	NULL
,	NULL
which	NULL
inhibits	NULL
the	NULL
vacu-olar	NULL
H1	NULL
ATPase	NULL
resulting	NULL
in	NULL
inhibition	NULL
of	NULL
endosomal	NULL
acidification	NULL
(	NULL
30	NULL
)	NULL
,	NULL
showed	NULL
a	NULL
dose-dependent	NULL
inhibition	NULL
of	NULL
class	NULL
II	NULL
antigen	NULL
processing	NULL
from	NULL
both	NULL
the	NULL
apical	NULL
and	NULL
basolateral	NULL
surfaces	NULL
,	NULL
although	NULL
the	NULL
inhibition	NULL
at	NULL
low	NULL
concentration	NULL
for	NULL
the	NULL
apical	NULL
processing	NULL
in	NULL
the	NULL
DR4	NULL
and	NULL
DR4/CIITA	NULL
transfectants	NULL
was	NULL
less	NULL
than	NULL
for	NULL
the	NULL
basolateral	NULL
processing	NULL
.	NULL

Stimulation	NULL
of	NULL
different	NULL
human	NULL
T	NULL
cell	NULL
clones	NULL
after	NULL
class	NULL
II	NULL
antigen	NULL
processing	NULL
initiated	NULL
from	NULL
the	NULL
apical	NULL
or	NULL
basolateral	NULL
surface	NULL
of	NULL
IECs	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
polarized	NULL
class	NULL
II	NULL
pathways	NULL
might	NULL
result	NULL
in	NULL
the	NULL
stimulation	NULL
of	NULL
different	NULL
subsets	NULL
of	NULL
T	NULL
lymphocytes	NULL
,	NULL
we	NULL
tested	NULL
the	NULL
responsiveness	NULL
of	NULL
several	NULL
CD4*	NULL
,	NULL
TT-specific	NULL
,	NULL
HLA-DRB1*0401-restricted	NULL
human	NULL
T	NULL
cell	NULL
clones	NULL
for	NULL
their	NULL
ability	NULL
to	NULL
proliferate	NULL
against	NULL
T84	NULL
DR4/CIITA	NULL
transfectants	NULL
exposed	NULL
to	NULL
intact	NULL
TT	NULL
from	NULL
their	NULL
apical	NULL
or	NULL
basolateral	NULL
surface	NULL
.	NULL

In	NULL
previous	NULL
studies	NULL
,	NULL
we	NULL
demonstrated	NULL
that	NULL
T84	NULL
HLA-DR	NULL
transfectants	NULL
could	NULL
be	NULL
used	NULL
as	NULL
efficient	NULL
APCs	NULL
for	NULL
human	NULL
T	NULL
DR4	NULL
transfectants	NULL
restores	NULL
the	NULL
ability	NULL
of	NULL
4	NULL
the	NULL
cells	NULL
to	NULL
efficiently	NULL
process	NULL
intact	NULL
TT	NULL
from	NULL
the	NULL
basolateral	NULL
surface	NULL
.	NULL

T84	NULL
HLA-DRB1*0401/CIITA	NULL
transfectants	NULL
were	NULL
used	NULL
in	NULL
polar	NULL
antigen-processing	NULL
assays	NULL
in	NULL
a	NULL
manner	NULL
identical	NULL
to	NULL
that	NULL
outlined	NULL
for	NULL
the	NULL
T84	NULL
DR4	NULL
transfectants	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

As	NULL
previ-ously	NULL
,	NULL
antigen	NULL
presentation	NULL
occurs	NULL
exclusively	NULL
at	NULL
the	NULL
basolateral	NULL
surface	NULL
,	NULL
and	NULL
``	NULL
api-cal	NULL
``	NULL
and	NULL
``	NULL
basolateral	NULL
``	NULL
correspond	NULL
to	NULL
the	NULL
surface	NULL
of	NULL
the	NULL
cell	NULL
exposed	NULL
to	NULL
intact	NULL
TT	NULL
.	NULL

Shown	NULL
are	NULL
antigen	NULL
dose-response	NULL
curves	NULL
after	NULL
4-h	NULL
exposure	NULL
of	NULL
intact	NULL
antigen	NULL
(	NULL
TT	NULL
)	NULL
from	NULL
the	NULL
apical	NULL
(	NULL
open	NULL
triangles	NULL
)	NULL
or	NULL
basolateral	NULL
(	NULL
open	NULL
squares	NULL
)	NULL
surfaces	NULL
.	NULL

By	NULL
flow	NULL
cytometry	NULL
using	NULL
an	NULL
HLA-DR4-specific	NULL
mAb	NULL
,	NULL
the	NULL
surface	NULL
expression	NULL
of	NULL
HLA-DRB1*0401	NULL
in	NULL
the	NULL
T84	NULL
DRB1	NULL
#	NULL
*0401	NULL
and	NULL
T84	NULL
DRB1*0401/CIITA	NULL
transfectants	NULL
was	NULL
indistinguishable	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

-A-	NULL
Apical	NULL
-B-	NULL
Basolateral	NULL
160	NULL
cell	NULL
clones	NULL
(	NULL
14	NULL
)	NULL
.	NULL

For	NULL
the	NULL
majority	NULL
of	NULL
clones	NULL
studied	NULL
,	NULL
pretreat-ment	NULL
of	NULL
the	NULL
T84	NULL
HLA-DR	NULL
transfectants	NULL
with	NULL
y-IFN	NULL
or	NULL
the	NULL
directed	NULL
expression	NULL
of	NULL
CIITA	NULL
in	NULL
the	NULL
APC	NULL
(	NULL
to	NULL
induce	NULL
Ii	NULL
and	NULL
HLA-DM	NULL
)	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
antigen	NULL
was	NULL
required	NULL
for	NULL
optimal	NULL
T	NULL
cell	NULL
stimulation	NULL
.	NULL

In	NULL
some	NULL
T	NULL
cell	NULL
clones	NULL
,	NULL
however	NULL
,	NULL
pre-treatment	NULL
with	NULL
y-IFN	NULL
or	NULL
expression	NULL
of	NULL
CIITA	NULL
in	NULL
the	NULL
APC	NULL
actually	NULL
inhibited	NULL
the	NULL
T	NULL
cell	NULL
responses	NULL
seen	NULL
,	NULL
and	NULL
optimal	NULL
T	NULL
cell	NULL
proliferation	NULL
was	NULL
observed	NULL
without	NULL
any	NULL
manipulation	NULL
of	NULL
the	NULL
T84	NULL
HLA-DR	NULL
transfectants	NULL
before	NULL
antigen	NULL
pulsing	NULL
and	NULL
T	NULL
cell	NULL
co-cultivation	NULL
.	NULL

Accordingly	NULL
,	NULL
we	NULL
chose	NULL
two	NULL
independent	NULL
T	NULL
cell	NULL
clones	NULL
for	NULL
these	NULL
studies	NULL
:	NULL
one	NULL
clone	NULL
(	NULL
designated	NULL
clone	NULL
2	NULL
)	NULL
that	NULL
was	NULL
enhanced	NULL
by	NULL
expression	NULL
of	NULL
CIITA	NULL
in	NULL
the	NULL
T84	NULL
DR4	NULL
transfectant	NULL
,	NULL
and	NULL
another	NULL
(	NULL
designated	NULL
clone	NULL
4	NULL
)	NULL
in	NULL
which	NULL
stimulation	NULL
was	NULL
optimal	NULL
without	NULL
CIITA	NULL
expression	NULL
in	NULL
the	NULL
APC	NULL
.	NULL

The	NULL
clonality	NULL
of	NULL
these	NULL
cells	NULL
was	NULL
confirmed	NULL
using	NULL
RT-PCR	NULL
and	NULL
Va-	NULL
and	NULL
VB-spe-cific	NULL
primers	NULL
(	NULL
see	NULL
Methods	NULL
section	NULL
)	NULL
.	NULL

When	NULL
assayed	NULL
using	NULL
polarized	NULL
T84	NULL
transfectants	NULL
on	NULL
transwells	NULL
,	NULL
these	NULL
two	NULL
clones	NULL
showed	NULL
distinct	NULL
patterns	NULL
of	NULL
responsiveness	NULL
to	NULL
T84	NULL
DR4/CIITA	NULL
transfectants	NULL
that	NULL
depended	NULL
on	NULL
which	NULL
side	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
apical	NULL
or	NULL
basolat-eral	NULL
)	NULL
antigen	NULL
was	NULL
added	NULL
to	NULL
the	NULL
T84	NULL
cells	NULL
.	NULL

As	NULL
seen	NULL
in	NULL
Fig	NULL
.	NULL

8	NULL
,	NULL
clone	NULL
2	NULL
was	NULL
stimulated	NULL
to	NULL
proliferate	NULL
by	NULL
T84	NULL
DR4/CIITA	NULL
cells	NULL
that	NULL
processed	NULL
antigen	NULL
from	NULL
the	NULL
basolateral	NULL
surface	NULL
but	NULL
not	NULL
from	NULL
identical	NULL
cells	NULL
exposed	NULL
to	NULL
antigen	NULL
from	NULL
the	NULL
apical	NULL
surface	NULL
.	NULL

In	NULL
marked	NULL
contrast	NULL
,	NULL
clone	NULL
4	NULL
proliferated	NULL
more	NULL
vigorously	NULL
against	NULL
T84	NULL
DR4/CIITA	NULL
cells	NULL
that	NULL
processed	NULL
antigen	NULL
from	NULL
the	NULL
apical	NULL
rather	NULL
than	NULL
from	NULL
the	NULL
basolateral	NULL
surface	NULL
.	NULL

Although	NULL
the	NULL
precise	NULL
peptides	NULL
recognized	NULL
by	NULL
these	NULL
individual	NULL
T	NULL
cell	NULL
clones	NULL
are	NULL
not	NULL
known	NULL
,	NULL
these	NULL
data	NULL
suggest	NULL
that	NULL
the	NULL
same	NULL
cell	NULL
exposed	NULL
to	NULL
an	NULL
identical	NULL
antigen	NULL
in	NULL
a	NULL
polarized	NULL
context	NULL
may	NULL
result	NULL
in	NULL
the	NULL
stimulation	NULL
of	NULL
distinct	NULL
(	NULL
but	NULL
potentially	NULL
overlapping	NULL
)	NULL
subsets	NULL
of	NULL
T	NULL
cells	NULL
.	NULL

Discussion	NULL
IECs	NULL
exist	NULL
in	NULL
a	NULL
highly	NULL
polarized	NULL
anatomical	NULL
context	NULL
,	NULL
with	NULL
high	NULL
concentrations	NULL
of	NULL
dietary	NULL
and	NULL
bacterial	NULL
antigens	NULL
at	NULL
the	NULL
mucosal	NULL
(	NULL
apical	NULL
)	NULL
surfaces	NULL
and	NULL
high	NULL
concentrations	NULL
of	NULL
lymphoid	NULL
cells	NULL
at	NULL
the	NULL
basolateral	NULL
surface	NULL
.	NULL

HLA	NULL
class	NULL
II	NULL
expression	NULL
is	NULL
polarized	NULL
in	NULL
Polarity	NULL
and	NULL
HLA	NULL
Class	NULL
II	NULL
_	NULL
799	NULL
Relative	NULL
Proliferation	NULL
(	NULL
%	NULL
)	NULL
[	NULL
Cytochalasin	NULL
DJ	NULL
,	NULL
ug/ml	NULL
120	NULL
100	NULL
80	NULL
60	NULL
40	NULL
Relative	NULL
Proliferation	NULL
(	NULL
%	NULL
)	NULL
20	NULL
0	NULL
5	NULL
10	NULL
15	NULL
20	NULL
25	NULL
[	NULL
Bafilomycin	NULL
]	NULL
,	NULL
nM	NULL
Figure	NULL
7	NULL
.	NULL

Drug	NULL
inhibition	NULL
of	NULL
class	NULL
II	NULL
processing	NULL
from	NULL
the	NULL
apical	NULL
and	NULL
basolateral	NULL
surfaces	NULL
of	NULL
T84	NULL
transfectants	NULL
.	NULL

T84	NULL
transfectants	NULL
were	NULL
treated	NULL
with	NULL
drug	NULL
for	NULL
1	NULL
h	NULL
at	NULL
37°C	NULL
before	NULL
addition	NULL
of	NULL
antigen	NULL
and	NULL
throughout	NULL
antigen	NULL
pulse	NULL
.	NULL

Processing	NULL
of	NULL
intact	NULL
TT	NULL
at	NULL
80	NULL
pg/ml	NULL
was	NULL
performed	NULL
in	NULL
an	NULL
identical	NULL
manner	NULL
to	NULL
that	NULL
shown	NULL
in	NULL
Figs	NULL
.	NULL

4	NULL
and	NULL
6	NULL
.	NULL

Shown	NULL
are	NULL
data	NULL
from	NULL
apical	NULL
processing	NULL
in	NULL
the	NULL
T84	NULL
DR4	NULL
transfectants	NULL
(	NULL
open	NULL
triangles	NULL
)	NULL
,	NULL
apical	NULL
(	NULL
open	NULL
squares	NULL
)	NULL
,	NULL
and	NULL
basolateral	NULL
(	NULL
open	NULL
circles	NULL
)	NULL
processing	NULL
in	NULL
the	NULL
T84	NULL
DR4	NULL
CIITA	NULL
transfectants	NULL
.	NULL

Percent	NULL
inhibition	NULL
refers	NULL
to	NULL
the	NULL
ratio	NULL
of	NULL
epm	NULL
(	NULL
with	NULL
drug	NULL
)	NULL
to	NULL
epm	NULL
(	NULL
without	NULL
drug	NULL
)	NULL
under	NULL
otherwise	NULL
identical	NULL
conditions	NULL
.	NULL

Standard	NULL
errors	NULL
were	NULL
<	NULL
15	NULL
%	NULL
.	NULL

these	NULL
cells	NULL
,	NULL
restricted	NULL
to	NULL
the	NULL
basolateral	NULL
membrane	NULL
,	NULL
and	NULL
we	NULL
now	NULL
demonstrate	NULL
that	NULL
there	NULL
is	NULL
a	NULL
remarkable	NULL
functional	NULL
polarity	NULL
to	NULL
the	NULL
antigen-processing	NULL
and	NULL
presentation	NULL
pathway	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

Using	NULL
three	NULL
independent	NULL
approaches-confocal	NULL
microscopy	NULL
,	NULL
selective	NULL
surface	NULL
biotinylation	NULL
,	NULL
and	NULL
HLA	NULL
class	NULL
II-mediated	NULL
peptide	NULL
presentation	NULL
to	NULL
antigen-specific	NULL
T	NULL
cells-we	NULL
demonstrate	NULL
that	NULL
the	NULL
surface	NULL
expression	NULL
of	NULL
HLA	NULL
class	NULL
II	NULL
expression	NULL
in	NULL
polarized	NULL
intestinal	NULL
epithelial	NULL
cells	NULL
is	NULL
restricted	NULL
to	NULL
the	NULL
basolateral	NULL
surface	NULL
.	NULL

These	NULL
data	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
pattern	NULL
of	NULL
surface	NULL
expression	NULL
of	NULL
MHC	NULL
class	NULL
II	NULL
antigens	NULL
in	NULL
the	NULL
human	NULL
(	NULL
15	NULL
,	NULL
800	NULL
_	NULL
Hershberg	NULL
et	NULL
al	NULL
.	NULL

31	NULL
)	NULL
and	NULL
rat	NULL
(	NULL
17	NULL
)	NULL
intestinal	NULL
epithelium	NULL
seen	NULL
using	NULL
immunohis-tochemistry	NULL
,	NULL
and	NULL
,	NULL
more	NULL
recently	NULL
,	NULL
in	NULL
MDCK	NULL
,	NULL
a	NULL
polarized	NULL
kidney	NULL
epithelial	NULL
cell	NULL
line	NULL
,	NULL
cells	NULL
transfected	NULL
with	NULL
HLA-DR1	NULL
(	NULL
32	NULL
)	NULL
.	NULL

With	NULL
regard	NULL
to	NULL
the	NULL
precise	NULL
sequences	NULL
required	NULL
for	NULL
basolateral	NULL
targeting	NULL
of	NULL
class	NULL
II	NULL
molecules	NULL
,	NULL
several	NULL
groups	NULL
have	NULL
recently	NULL
shown	NULL
that	NULL
sequences	NULL
within	NULL
the	NULL
cytoplasmic	NULL
domain	NULL
of	NULL
the	NULL
Ii	NULL
can	NULL
direct	NULL
the	NULL
expression	NULL
of	NULL
a	NULL
chimeric	NULL
molecule	NULL
to	NULL
the	NULL
basolateral	NULL
surface	NULL
of	NULL
polarized	NULL
MDCK	NULL
cells	NULL
(	NULL
32	NULL
,	NULL
33	NULL
)	NULL
.	NULL

The	NULL
Ii	NULL
is	NULL
physically	NULL
associated	NULL
with	NULL
nascent	NULL
HLA	NULL
class	NULL
II	NULL
molecules	NULL
,	NULL
but	NULL
is	NULL
progressively	NULL
trimmed	NULL
to	NULL
the	NULL
CLIP	NULL
fragment	NULL
(	NULL
which	NULL
does	NULL
not	NULL
contain	NULL
the	NULL
basolateral	NULL
targeting	NULL
sequence	NULL
)	NULL
as	NULL
the	NULL
nascent	NULL
class	NULL
II	NULL
complex	NULL
migrates	NULL
to	NULL
an	NULL
acidic	NULL
,	NULL
peptide-loading	NULL
compartment	NULL
referred	NULL
to	NULL
as	NULL
CIHIV	NULL
(	NULL
or	NULL
MIIC	NULL
)	NULL
before	NULL
transport	NULL
to	NULL
the	NULL
cell	NULL
surface	NULL
(	NULL
reviewed	NULL
in	NULL
11	NULL
and	NULL
12	NULL
)	NULL
.	NULL

Hence	NULL
,	NULL
the	NULL
physiological	NULL
significance	NULL
of	NULL
Ii	NULL
in	NULL
directing	NULL
class	NULL
II	NULL
molecules	NULL
to	NULL
the	NULL
basolateral	NULL
surface	NULL
of	NULL
polarized	NULL
cells	NULL
remains	NULL
unclear	NULL
.	NULL

Our	NULL
data	NULL
using	NULL
T84	NULL
cells	NULL
engineered	NULL
to	NULL
express	NULL
HLA-DR	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
Ii	NULL
clearly	NULL
reveal	NULL
that	NULL
basolateral	NULL
targeting	NULL
of	NULL
class	NULL
II	NULL
molecules	NULL
does	NULL
not	NULL
require	NULL
Ii	NULL
.	NULL

These	NULL
data	NULL
are	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
findings	NULL
that	NULL
class	NULL
II	NULL
expression	NULL
is	NULL
mostly	NULL
restricted	NULL
to	NULL
the	NULL
basolateral	NULL
surface	NULL
in	NULL
MDCK	NULL
cells	NULL
expressing	NULL
HLA-DR	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
Ii	NULL
(	NULL
32	NULL
)	NULL
.	NULL

The	NULL
precise	NULL
molecular	NULL
basis	NULL
of	NULL
the	NULL
spatially-restricted	NULL
pattern	NULL
of	NULL
class	NULL
II	NULL
expression	NULL
at	NULL
the	NULL
basolateral	NULL
surface	NULL
without	NULL
Ii	NULL
has	NULL
not	NULL
been	NULL
investigated	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
cytoplasmic	NULL
tail	NULL
of	NULL
the	NULL
B	NULL
chain	NULL
of	NULL
class	NULL
II	NULL
contains	NULL
a	NULL
di-leucine	NULL
motif	NULL
that	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
recycling	NULL
from	NULL
the	NULL
cell	NULL
surface	NULL
(	NULL
34	NULL
,	NULL
35	NULL
)	NULL
,	NULL
endosomal	NULL
localization	NULL
(	NULL
36	NULL
)	NULL
,	NULL
and	NULL
basolateral	NULL
targeting	NULL
(	NULL
36	NULL
and	NULL
reviewed	NULL
in	NULL
37	NULL
)	NULL
.	NULL

It	NULL
is	NULL
also	NULL
possible	NULL
that	NULL
sequences	NULL
in	NULL
the	NULL
cytoplasmic	NULL
tail	NULL
of	NULL
the	NULL
«	NULL
chain	NULL
of	NULL
the	NULL
class	NULL
II	NULL
heterodimer	NULL
,	NULL
which	NULL
have	NULL
also	NULL
been	NULL
implicated	NULL
in	NULL
recycling	NULL
of	NULL
mature	NULL
class	NULL
II	NULL
molecules	NULL
from	NULL
the	NULL
cell	NULL
surface	NULL
(	NULL
35	NULL
)	NULL
,	NULL
may	NULL
contribute	NULL
to	NULL
basolateral	NULL
targeting	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
the	NULL
restricted	NULL
expression	NULL
of	NULL
HLA	NULL
class	NULL
II	NULL
molecules	NULL
at	NULL
the	NULL
basolateral	NULL
surface	NULL
,	NULL
there	NULL
was	NULL
remarkable	NULL
polarity	NULL
with	NULL
regard	NULL
to	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
epithelial	NULL
cell	NULL
to	NULL
process	NULL
intact	NULL
antigen	NULL
with	NULL
the	NULL
processing	NULL
of	NULL
TT	NULL
initiated	NULL
only	NULL
from	NULL
the	NULL
apical	NULL
surface	NULL
in	NULL
T84	NULL
cells	NULL
directed	NULL
to	NULL
express	NULL
HLA-DR	NULL
molecules	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
Ii	NULL
and	NULL
HLA-DM	NULL
.	NULL

To	NULL
be	NULL
able	NULL
to	NULL
study	NULL
the	NULL
potential	NULL
effects	NULL
of	NULL
y-IFN	NULL
on	NULL
polarized	NULL
aspects	NULL
of	NULL
class	NULL
II	NULL
processing	NULL
in	NULL
IEC	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
the	NULL
untoward	NULL
effects	NULL
of	NULL
this	NULL
cytokine	NULL
in	NULL
disrupting	NULL
the	NULL
barrier	NULL
function	NULL
of	NULL
T84	NULL
monolayers	NULL
,	NULL
we	NULL
directed	NULL
the	NULL
overexpression	NULL
of	NULL
CIITA	NULL
(	NULL
with	NULL
the	NULL
concomitant	NULL
induction	NULL
of	NULL
Ii	NULL
and	NULL
HLA-DM	NULL
expression	NULL
)	NULL
in	NULL
the	NULL
T84	NULL
HLA-DR	NULL
transfectants	NULL
.	NULL

We	NULL
observed	NULL
that	NULL
antigen	NULL
processing	NULL
was	NULL
more	NULL
efficient	NULL
in	NULL
the	NULL
CHTA	NULL
``	NULL
co-transfectants	NULL
``	NULL
and	NULL
that	NULL
,	NULL
strikingly	NULL
,	NULL
both	NULL
polar	NULL
surfaces	NULL
were	NULL
capable	NULL
of	NULL
initiating	NULL
class	NULL
II	NULL
antigen	NULL
processing	NULL
.	NULL

In	NULL
this	NULL
context	NULL
,	NULL
several	NULL
features	NULL
of	NULL
the	NULL
CHTA	NULL
transfectants	NULL
are	NULL
noteworthy	NULL
.	NULL

First	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
report	NULL
of	NULL
Siegrist	NULL
et	NULL
al	NULL
.	NULL

,	NULL
which	NULL
detailed	NULL
the	NULL
inability	NULL
of	NULL
melanoma	NULL
cells	NULL
overexpressing	NULL
CIITA	NULL
to	NULL
efficiently	NULL
process	NULL
intact	NULL
antigen	NULL
(	NULL
38	NULL
)	NULL
,	NULL
the	NULL
overexpression	NULL
of	NULL
CIITA	NULL
in	NULL
T84	NULL
cells	NULL
was	NULL
sufficient	NULL
to	NULL
confer	NULL
efficient	NULL
class	NULL
II	NULL
antigen	NULL
processing	NULL
that	NULL
consistently	NULL
equaled	NULL
or	NULL
exceeded	NULL
that	NULL
seen	NULL
after	NULL
treatment	NULL
with	NULL
y-IFN	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
the	NULL
effect	NULL
of	NULL
CHTA	NULL
is	NULL
not	NULL
identical	NULL
in	NULL
all	NULL
``	NULL
nonprofes-sional	NULL
``	NULL
antigen-presenting	NULL
cells	NULL
.	NULL

IECs	NULL
,	NULL
such	NULL
as	NULL
T84	NULL
cells	NULL
,	NULL
may	NULL
be	NULL
especially	NULL
proficient	NULL
in	NULL
class	NULL
II	NULL
processing	NULL
in	NULL
the	NULL
setting	NULL
of	NULL
CIITA	NULL
expression	NULL
because	NULL
they	NULL
constitutively	NULL
express	NULL
high	NULL
levels	NULL
of	NULL
cysteine	NULL
and	NULL
aspartyl	NULL
proteases	NULL
(	NULL
14	NULL
)	NULL
including	NULL
cathep-sin	NULL
S	NULL
(	NULL
R.	NULL
Hershberg	NULL
and	NULL
H.	NULL
Chapman	NULL
,	NULL
unpublished	NULL
data	NULL
)	NULL
.	NULL

Sec-ond	NULL
,	NULL
the	NULL
directed	NULL
overexpression	NULL
of	NULL
CIITA	NULL
enhanced	NULL
antigen	NULL
processing	NULL
in	NULL
T84	NULL
cells	NULL
without	NULL
a	NULL
concomitant	NULL
decrease	NULL
in	NULL
bar	NULL
120000	NULL
|	NULL
clone	NULL
02	NULL
clone	NULL
04	NULL
|	NULL
-	NULL
100000	NULL
+	NULL
3	NULL
a	NULL
.	NULL

&	NULL
5	NULL
80000	NULL
+	NULL
©	NULL
6	NULL
&	NULL
s0000	NULL
o	NULL
0	NULL
£	NULL
n	NULL
”	NULL
I	NULL
.	NULL

40000	NULL
+	NULL
T	NULL
20000	NULL
+	NULL
0	NULL
[	NULL
--	NULL
=	NULL
If	NULL
mmm	NULL
prem	NULL
C	NULL
--	NULL
4	NULL
AP	NULL
BL	NULL
AP	NULL
BL	NULL
0	NULL
80	NULL
0	NULL
80	NULL
0	NULL
80	NULL
0	NULL
80	NULL
[	NULL
TT	NULL
]	NULL
,	NULL
ug/ml	NULL
m	NULL
a	NULL
[	NULL
7	NULL
&	NULL
f	NULL
&	NULL
'	NULL
H	NULL
«	NULL
a	NULL
(	NULL
7	NULL
HLA-DR	NULL
``	NULL
li	NULL
+/-HLA-DM	NULL
+/-	NULL
Non-Inflamed	NULL
Figure	NULL
8	NULL
.	NULL

Different	NULL
human	NULL
T	NULL
cell	NULL
clones	NULL
are	NULL
selectively	NULL
stimulated	NULL
after	NULL
class	NULL
II	NULL
processing	NULL
initiated	NULL
from	NULL
the	NULL
apical	NULL
or	NULL
basolateral	NULL
surface	NULL
with	NULL
the	NULL
same	NULL
antigen	NULL
.	NULL

Stimulation	NULL
of	NULL
two	NULL
different	NULL
TT-specific	NULL
HLA-DRB1*0401-restricted	NULL
T	NULL
cell	NULL
clones	NULL
(	NULL
designated	NULL
clone	NULL
2	NULL
and	NULL
4	NULL
,	NULL
respec-tively	NULL
)	NULL
by	NULL
T84	NULL
DR4	NULL
CIITA	NULL
transfectants	NULL
on	NULL
transwells	NULL
pulsed	NULL
with	NULL
80	NULL
pg/ml	NULL
TT	NULL
from	NULL
the	NULL
apical	NULL
or	NULL
basolateral	NULL
surface	NULL
,	NULL
as	NULL
indicated	NULL
.	NULL

After	NULL
24	NULL
h	NULL
of	NULL
co-culture	NULL
,	NULL
the	NULL
T	NULL
cell	NULL
clones	NULL
were	NULL
removed	NULL
from	NULL
the	NULL
top	NULL
chamber	NULL
of	NULL
the	NULL
transwells	NULL
and	NULL
cultured	NULL
in	NULL
96-well	NULL
round	NULL
bottom	NULL
plates	NULL
(	NULL
without	NULL
further	NULL
addition	NULL
of	NULL
antigen	NULL
or	NULL
APC	NULL
)	NULL
for	NULL
48	NULL
h.	NULL
1.0	NULL
wCi	NULL
'	NULL
[	NULL
H	NULL
]	NULL
thymidine	NULL
was	NULL
present	NULL
during	NULL
the	NULL
last	NULL
18	NULL
h	NULL
of	NULL
culture	NULL
,	NULL
and	NULL
'	NULL
[	NULL
H	NULL
]	NULL
thymidine	NULL
uptake	NULL
was	NULL
measured	NULL
.	NULL

All	NULL
points	NULL
were	NULL
done	NULL
in	NULL
triplicate	NULL
and	NULL
standard	NULL
error	NULL
is	NULL
indicated	NULL
.	NULL

HLA-DrR	NULL
``	NULL
S	NULL
``	NULL
li	NULL
++	NULL
HLA-DM	NULL
++	NULL
Figure	NULL
9	NULL
.	NULL

A	NULL
model	NULL
for	NULL
polarized	NULL
HLA	NULL
class	NULL
II	NULL
antigen	NULL
processing	NULL
by	NULL
IECs	NULL
.	NULL

Inflammatory	NULL
stimuli	NULL
,	NULL
such	NULL
as	NULL
y-IFN	NULL
,	NULL
result	NULL
in	NULL
the	NULL
exposure	NULL
of	NULL
the	NULL
basolateral	NULL
surface	NULL
to	NULL
luminal	NULL
(	NULL
apical	NULL
)	NULL
antigens	NULL
via	NULL
``	NULL
leaky	NULL
``	NULL
tight	NULL
junctions	NULL
(	NULL
TJ	NULL
)	NULL
concomitant	NULL
with	NULL
the	NULL
induction	NULL
of	NULL
HLA-DR	NULL
,	NULL
Ii	NULL
,	NULL
and	NULL
HLA-DM	NULL
.	NULL

Regardless	NULL
of	NULL
the	NULL
surface	NULL
of	NULL
antigen	NULL
exposure	NULL
,	NULL
peptide	NULL
presentation	NULL
via	NULL
class	NULL
II	NULL
is	NULL
restricted	NULL
to	NULL
the	NULL
basolateral	NULL
surface	NULL
of	NULL
the	NULL
cell	NULL
.	NULL

The	NULL
patterned	NULL
and	NULL
filled	NULL
circles	NULL
represent	NULL
distinct	NULL
peptide	NULL
epitopes	NULL
within	NULL
a	NULL
given	NULL
protein	NULL
antigen	NULL
revealing	NULL
nonidentical	NULL
,	NULL
but	NULL
potentially	NULL
overlapping	NULL
,	NULL
HLA-peptide	NULL
complexes	NULL
generated	NULL
from	NULL
epithelial	NULL
cells	NULL
from	NULL
inflamed	NULL
or	NULL
noninflamed	NULL
mucosa	NULL
.	NULL

Polarity	NULL
and	NULL
HLA	NULL
Class	NULL
II	NULL
__	NULL
801	NULL
rier	NULL
function	NULL
.	NULL

This	NULL
demonstrates	NULL
that	NULL
the	NULL
effects	NULL
of	NULL
y-IFN	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
``	NULL
physiological	NULL
``	NULL
epithelial	NULL
cell	NULL
functions	NULL
,	NULL
such	NULL
as	NULL
tight	NULL
junction	NULL
permeability	NULL
,	NULL
may	NULL
be	NULL
dissociated	NULL
at	NULL
the	NULL
molecular	NULL
level	NULL
from	NULL
its	NULL
effect	NULL
on	NULL
the	NULL
induced	NULL
expression	NULL
of	NULL
immuno-logically	NULL
relevant	NULL
molecules	NULL
,	NULL
such	NULL
as	NULL
Ii	NULL
and	NULL
HLA-DM	NULL
.	NULL

The	NULL
polarized	NULL
trafficking	NULL
of	NULL
antigen	NULL
via	NULL
HLA	NULL
class	NULL
II	NULL
in	NULL
epithelial	NULL
cells	NULL
highlight	NULL
the	NULL
complexity	NULL
of	NULL
endosomal	NULL
structures	NULL
in	NULL
polarized	NULL
epithelial	NULL
cells	NULL
,	NULL
with	NULL
distinct	NULL
apical	NULL
and	NULL
basolateral	NULL
structures	NULL
that	NULL
communicate	NULL
somewhat	NULL
through	NULL
a	NULL
``	NULL
common	NULL
``	NULL
endosomal	NULL
pathway	NULL
(	NULL
39	NULL
,	NULL
40	NULL
)	NULL
.	NULL

Based	NULL
on	NULL
the	NULL
inhibition	NULL
of	NULL
both	NULL
apical	NULL
and	NULL
basolateral	NULL
processing	NULL
by	NULL
the	NULL
proton	NULL
pump	NULL
inhibitor	NULL
bafilomycin	NULL
,	NULL
processing	NULL
of	NULL
antigen	NULL
from	NULL
both	NULL
polarized	NULL
surfaces	NULL
requires	NULL
transit	NULL
through	NULL
an	NULL
acidic	NULL
compartment	NULL
.	NULL

These	NULL
data	NULL
are	NULL
consistent	NULL
with	NULL
several	NULL
studies	NULL
detailing	NULL
the	NULL
trafficking	NULL
of	NULL
nascent	NULL
and	NULL
recycled	NULL
class	NULL
II	NULL
through	NULL
acidic	NULL
endosomal	NULL
structures	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
Ii	NULL
(	NULL
34	NULL
,	NULL
41	NULL
)	NULL
.	NULL

The	NULL
selective	NULL
stimulation	NULL
of	NULL
several	NULL
CD4*	NULL
T	NULL
cell	NULL
clones	NULL
depending	NULL
on	NULL
the	NULL
route	NULL
of	NULL
antigen	NULL
uptake	NULL
suggests	NULL
that	NULL
processing	NULL
from	NULL
the	NULL
apical	NULL
or	NULL
basolateral	NULL
surface	NULL
has	NULL
the	NULL
capacity	NULL
to	NULL
generate	NULL
different	NULL
HLA	NULL
class	NULL
II-peptide	NULL
complexes	NULL
from	NULL
the	NULL
same	NULL
antigen	NULL
.	NULL

This	NULL
is	NULL
reminiscent	NULL
of	NULL
other	NULL
reports	NULL
that	NULL
the	NULL
processing	NULL
and	NULL
presentation	NULL
of	NULL
specific	NULL
peptide	NULL
epitopes	NULL
within	NULL
the	NULL
same	NULL
protein	NULL
antigen	NULL
(	NULL
34	NULL
,	NULL
41	NULL
)	NULL
or	NULL
virus	NULL
particle	NULL
(	NULL
42	NULL
)	NULL
appear	NULL
highly	NULL
dependent	NULL
on	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
Ii	NULL
and/or	NULL
HLA-DM	NULL
(	NULL
reviewed	NULL
in	NULL
43	NULL
)	NULL
.	NULL

The	NULL
data	NULL
presented	NULL
here	NULL
provide	NULL
the	NULL
first	NULL
polarized	NULL
context	NULL
for	NULL
such	NULL
Ii	NULL
and	NULL
HLA-DM	NULL
independent	NULL
class	NULL
II	NULL
processing	NULL
events	NULL
,	NULL
and	NULL
are	NULL
likely	NULL
to	NULL
be	NULL
of	NULL
physiological	NULL
sig-nificance	NULL
,	NULL
given	NULL
both	NULL
the	NULL
high	NULL
concentration	NULL
and	NULL
large	NULL
number	NULL
of	NULL
food	NULL
and	NULL
microbial	NULL
antigens	NULL
constantly	NULL
in	NULL
contact	NULL
with	NULL
the	NULL
intestinal	NULL
epithelium	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
we	NULL
identify	NULL
distinct	NULL
features	NULL
of	NULL
HLA	NULL
class	NULL
II	NULL
processing	NULL
after	NULL
exposure	NULL
of	NULL
either	NULL
the	NULL
apical	NULL
or	NULL
basolateral	NULL
surface	NULL
to	NULL
a	NULL
protein	NULL
antigen	NULL
,	NULL
and	NULL
a	NULL
schematic	NULL
model	NULL
is	NULL
presented	NULL
in	NULL
Fig	NULL
.	NULL

9	NULL
.	NULL

As	NULL
shown	NULL
,	NULL
the	NULL
spatially	NULL
restricted	NULL
pattern	NULL
of	NULL
class	NULL
II	NULL
expression	NULL
on	NULL
the	NULL
basolateral	NULL
surface	NULL
of	NULL
polarized	NULL
IECs	NULL
facilitates	NULL
the	NULL
presentation	NULL
of	NULL
antigens	NULL
to	NULL
T	NULL
cells	NULL
within	NULL
the	NULL
epithelium	NULL
and	NULL
in	NULL
the	NULL
underlying	NULL
lamina	NULL
propria	NULL
.	NULL

This	NULL
polarized	NULL
peptide	NULL
presentation	NULL
via	NULL
HLA	NULL
class	NULL
II	NULL
at	NULL
the	NULL
basolateral	NULL
surface	NULL
occurs	NULL
whether	NULL
the	NULL
intact	NULL
antigen	NULL
is	NULL
internalized	NULL
and	NULL
processed	NULL
from	NULL
the	NULL
apical	NULL
or	NULL
basolateral	NULL
surface	NULL
of	NULL
the	NULL
cell	NULL
.	NULL

The	NULL
combined	NULL
effect	NULL
of	NULL
proinflammatory	NULL
cytokines	NULL
such	NULL
as	NULL
y-IFN	NULL
within	NULL
the	NULL
intestinal	NULL
mucosa	NULL
in	NULL
altering	NULL
barrier	NULL
function	NULL
(	NULL
allow-ing	NULL
increased	NULL
paracellular	NULL
passage	NULL
of	NULL
luminal	NULL
antigens	NULL
across	NULL
the	NULL
epithelium	NULL
)	NULL
,	NULL
coupled	NULL
with	NULL
the	NULL
facilitation	NULL
of	NULL
efficient	NULL
antigen	NULL
processing	NULL
and	NULL
presentation	NULL
by	NULL
intestinal	NULL
epithelial	NULL
cells	NULL
,	NULL
may	NULL
help	NULL
to	NULL
explain	NULL
the	NULL
exaggerated	NULL
and	NULL
often	NULL
intractable	NULL
inflammatory	NULL
response	NULL
seen	NULL
in	NULL
the	NULL
intestinal	NULL
mucosa	NULL
of	NULL
patients	NULL
with	NULL
inflammatory	NULL
bowel	NULL
disease	NULL
.	NULL

This	NULL
may	NULL
result	NULL
in	NULL
the	NULL
processing	NULL
and	NULL
presentation	NULL
of	NULL
distinct	NULL
peptide	NULL
epitopes	NULL
from	NULL
luminal	NULL
antigens	NULL
by	NULL
epithelial	NULL
cells	NULL
from	NULL
inflamed	NULL
(	NULL
in	NULL
contrast	NULL
to	NULL
``	NULL
noninflamed	NULL
``	NULL
)	NULL
mucosa	NULL
.	NULL

Whether	NULL
the	NULL
``	NULL
sampling	NULL
``	NULL
of	NULL
luminal	NULL
antigens	NULL
via	NULL
apical	NULL
processing	NULL
and	NULL
presentation	NULL
by	NULL
class	NULL
II	NULL
molecules	NULL
of	NULL
certain	NULL
peptide	NULL
epitopes	NULL
by	NULL
the	NULL
intestinal	NULL
epithelium	NULL
to	NULL
CD4*T	NULL
cells	NULL
in	NULL
the	NULL
lamina	NULL
propria	NULL
in	NULL
the	NULL
noninflamed	NULL
mucosa	NULL
contributes	NULL
to	NULL
the	NULL
generation	NULL
of	NULL
oral	NULL
tolerance	NULL
remains	NULL
a	NULL
matter	NULL
for	NULL
speculation	NULL
.	NULL

Consistent	NULL
with	NULL
the	NULL
data	NULL
presented	NULL
here	NULL
,	NULL
proinflammatory	NULL
cytokines	NULL
are	NULL
likely	NULL
to	NULL
dramatically	NULL
alter	NULL
the	NULL
delicate	NULL
balance	NULL
between	NULL
tolerance	NULL
and	NULL
responsiveness	NULL
in	NULL
the	NULL
intestinal	NULL
mucosa	NULL
.	NULL

In	NULL
this	NULL
context	NULL
it	NULL
is	NULL
notable	NULL
that	NULL
y-IFN	NULL
administration	NULL
to	NULL
mice	NULL
can	NULL
abrogate	NULL
the	NULL
tolerogenic	NULL
effect	NULL
of	NULL
orally	NULL
administered	NULL
antigen	NULL
(	NULL
44	NULL
)	NULL
,	NULL
yet	NULL
oral	NULL
tolerance	NULL
can	NULL
occur	NULL
in	NULL
y-IFN-receptor~'~	NULL
mice	NULL
(	NULL
45	NULL
)	NULL
.	NULL

802	NULL
-	NULL
Hershberg	NULL
et	NULL
al	NULL
.	NULL

Acknowledgments	NULL
We	NULL
gratefully	NULL
acknowledge	NULL
Linda	NULL
Wicker	NULL
and	NULL
Dennis	NULL
Zaller	NULL
(	NULL
Merck	NULL
Research	NULL
Laboratories	NULL
)	NULL
for	NULL
T	NULL
cell	NULL
hybridomas	NULL
,	NULL
Jane	NULL
Buckner	NULL
and	NULL
Steve	NULL
Ziegler	NULL
(	NULL
Virginia	NULL
Mason	NULL
Research	NULL
Center	NULL
)	NULL
for	NULL
critical	NULL
review	NULL
of	NULL
the	NULL
manuscript	NULL
,	NULL
Nicky	NULL
Ducommun	NULL
for	NULL
help	NULL
with	NULL
preparation	NULL
of	NULL
the	NULL
manuscript	NULL
,	NULL
and	NULL
Mari	NULL
Hall	NULL
for	NULL
expert	NULL
assistance	NULL
with	NULL
preparation	NULL
of	NULL
figures	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
a	NULL
First	NULL
Award	NULL
from	NULL
Crohn	NULL
's	NULL
and	NULL
Colitis	NULL
Foundation	NULL
of	NULL
America	NULL
(	NULL
R.M	NULL
.	NULL

Hershberg	NULL
)	NULL
;	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
(	NULL
Bethesda	NULL
,	NULL
MD	NULL
)	NULL
grant	NULL
AI50902	NULL
(	NULL
J.S	NULL
.	NULL

Lee	NULL
)	NULL
;	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
grant	NULL
AI38913	NULL
(	NULL
G.T	NULL
.	NULL

Nepom	NULL
)	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Jung	NULL
,	NULL
H.C.	NULL
,	NULL
L.	NULL
Eckmann	NULL
,	NULL
S.-K.	NULL
Yang	NULL
,	NULL
A.	NULL
Panja	NULL
,	NULL
J.	NULL
Fierer	NULL
,	NULL
E.	NULL
Morzycka-Wroblewska	NULL
,	NULL
and	NULL
MF	NULL
.	NULL

Kagnoff	NULL
.	NULL

1995	NULL
.	NULL

A	NULL
distinct	NULL
array	NULL
of	NULL
proinflammatory	NULL
cytokines	NULL
is	NULL
expressed	NULL
in	NULL
human	NULL
colon	NULL
epithelial	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
bacterial	NULL
in-vasion	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

95:55-65	NULL
.	NULL

2	NULL
.	NULL

Cepek	NULL
,	NULL
KL	NULL
.	NULL

,	NULL
S.K	NULL
.	NULL

Shaw	NULL
,	NULL
C.M	NULL
.	NULL

Parker	NULL
,	NULL
G.J	NULL
.	NULL

Russell	NULL
,	NULL
J.S	NULL
.	NULL

Morrow	NULL
,	NULL
D.L	NULL
.	NULL

Rimm	NULL
,	NULL
and	NULL
M.B	NULL
.	NULL

Brenner	NULL
.	NULL

1994	NULL
.	NULL

Adhesion	NULL
between	NULL
epithelial	NULL
cells	NULL
and	NULL
T	NULL
lymphocytes	NULL
mediated	NULL
by	NULL
E-cadherin	NULL
and	NULL
the	NULL
alpha	NULL
E	NULL
beta	NULL
7	NULL
integrin	NULL
.	NULL

Nature	NULL
.	NULL

372	NULL
:	NULL
190-193	NULL
.	NULL

3	NULL
.	NULL

Chen	NULL
,	NULL
Y.	NULL
,	NULL
J.	NULL
Inobe	NULL
,	NULL
and	NULL
H.L	NULL
.	NULL

Weiner	NULL
.	NULL

1995	NULL
.	NULL

Induction	NULL
of	NULL
oral	NULL
tolerance	NULL
to	NULL
myelin	NULL
basic	NULL
protein	NULL
in	NULL
CD8-depleted	NULL
mice	NULL
:	NULL
both	NULL
CD4*	NULL
and	NULL
CD8*	NULL
cells	NULL
mediate	NULL
active	NULL
suppression	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

155:910-916	NULL
.	NULL

4	NULL
.	NULL

Garside	NULL
,	NULL
P.	NULL
,	NULL
M.	NULL
Steel	NULL
,	NULL
F.Y	NULL
.	NULL

Liew	NULL
,	NULL
and	NULL
A.M.	NULL
Mowat	NULL
.	NULL

1995	NULL
.	NULL

CD4*	NULL
but	NULL
not	NULL
CD8	NULL
T	NULL
cells	NULL
are	NULL
required	NULL
for	NULL
the	NULL
induction	NULL
of	NULL
oral	NULL
tolerance	NULL
.	NULL

Int	NULL
.	NULL

Immunol	NULL
.	NULL

7	NULL
:	NULL
501-504	NULL
.	NULL

5	NULL
.	NULL

Barone	NULL
,	NULL
K.S	NULL
.	NULL

,	NULL
S.L	NULL
.	NULL

Jain	NULL
,	NULL
and	NULL
J.G	NULL
.	NULL

Michael	NULL
.	NULL

1995	NULL
.	NULL

Effect	NULL
of	NULL
in	NULL
vivo	NULL
depletion	NULL
of	NULL
CD4*	NULL
and	NULL
CD8*	NULL
cells	NULL
on	NULL
the	NULL
induction	NULL
and	NULL
maintenance	NULL
of	NULL
oral	NULL
tolerance	NULL
.	NULL

Cell	NULL
.	NULL

Immunol	NULL
.	NULL

163:19-29	NULL
.	NULL

6	NULL
.	NULL

Powrie	NULL
,	NULL
F.	NULL
1995	NULL
.	NULL

T	NULL
cells	NULL
in	NULL
inflammatory	NULL
bowel	NULL
disease	NULL
:	NULL
protective	NULL
and	NULL
pathogenic	NULL
roles	NULL
.	NULL

Immunity	NULL
.	NULL

3:171-174	NULL
.	NULL

7	NULL
.	NULL

Germain	NULL
,	NULL
R.N	NULL
.	NULL

1994	NULL
.	NULL

MHC-dependent	NULL
antigen	NULL
processing	NULL
and	NULL
peptide	NULL
presentation	NULL
:	NULL
providing	NULL
ligands	NULL
for	NULL
T	NULL
lymphocyte	NULL
activation	NULL
.	NULL

Cell	NULL
.	NULL

76:287-299	NULL
.	NULL

8	NULL
.	NULL

Mayer	NULL
,	NULL
L.	NULL
,	NULL
D.	NULL
Eisenhardt	NULL
,	NULL
P.	NULL
Salomon	NULL
,	NULL
W.	NULL
Bauer	NULL
,	NULL
R.	NULL
Plous	NULL
,	NULL
and	NULL
L.	NULL
Picci-nini	NULL
.	NULL

1991	NULL
.	NULL

Expression	NULL
of	NULL
class	NULL
II	NULL
molecules	NULL
on	NULL
intestinal	NULL
epithelial	NULL
cells	NULL
in	NULL
hu-mans	NULL
.	NULL

Differences	NULL
between	NULL
normal	NULL
and	NULL
inflammatory	NULL
bowel	NULL
disease	NULL
.	NULL

Gastroen-terology	NULL
.	NULL

100:3-12	NULL
.	NULL

9	NULL
.	NULL

Bland	NULL
,	NULL
P.W	NULL
.	NULL

,	NULL
and	NULL
C.V.	NULL
Whiting	NULL
.	NULL

1992	NULL
.	NULL

Induction	NULL
of	NULL
MHC	NULL
class	NULL
II	NULL
gene	NULL
products	NULL
in	NULL
rat	NULL
intestinal	NULL
epithelium	NULL
during	NULL
graft-versus-host	NULL
disease	NULL
and	NULL
effects	NULL
on	NULL
the	NULL
immune	NULL
function	NULL
of	NULL
the	NULL
epithelium	NULL
.	NULL

Immunology	NULL
.	NULL

75:366-371	NULL
.	NULL

10	NULL
.	NULL

Ciclitira	NULL
,	NULL
P.J	NULL
.	NULL

,	NULL
J.M	NULL
.	NULL

Nelufer	NULL
,	NULL
H.J	NULL
.	NULL

Ellis	NULL
,	NULL
and	NULL
D.J	NULL
.	NULL

Evans	NULL
.	NULL

1986	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
gluten	NULL
on	NULL
HLA-DR	NULL
in	NULL
the	NULL
small	NULL
intestinal	NULL
epithelium	NULL
of	NULL
patients	NULL
with	NULL
Coe-liac	NULL
disease	NULL
.	NULL

Clin	NULL
.	NULL

Exp	NULL
.	NULL

Immunol	NULL
.	NULL

63:101-104	NULL
.	NULL

11	NULL
.	NULL

Wolf	NULL
,	NULL
P.R	NULL
.	NULL

,	NULL
and	NULL
H.L	NULL
.	NULL

Ploegh	NULL
.	NULL

1995	NULL
.	NULL

How	NULL
MHC	NULL
class	NULL
II	NULL
molecules	NULL
acquire	NULL
peptide	NULL
cargo	NULL
:	NULL
biosynthesis	NULL
and	NULL
trafficking	NULL
through	NULL
the	NULL
endocytic	NULL
pathway	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Cell	NULL
Dev	NULL
.	NULL

Biol	NULL
.	NULL

11:267-306	NULL
.	NULL

12	NULL
.	NULL

Cresswell	NULL
,	NULL
P.	NULL
1994	NULL
.	NULL

Assembly	NULL
,	NULL
transport	NULL
,	NULL
and	NULL
function	NULL
of	NULL
MHC	NULL
class	NULL
II	NULL
molecules	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

12:259-293	NULL
.	NULL

13	NULL
.	NULL

Kaiserlian	NULL
,	NULL
D.	NULL
,	NULL
K.	NULL
Vidal	NULL
,	NULL
and	NULL
J.-P.	NULL
Revillard	NULL
.	NULL

1989	NULL
.	NULL

Murine	NULL
enterocytes	NULL
can	NULL
present	NULL
soluble	NULL
antigen	NULL
to	NULL
specific	NULL
class	NULL
I-restricted	NULL
CD4*	NULL
T	NULL
cells	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

19:1513-1516	NULL
.	NULL

14	NULL
.	NULL

Hershberg	NULL
,	NULL
R.M	NULL
.	NULL

,	NULL
P.E	NULL
.	NULL

Framson	NULL
,	NULL
D.H.	NULL
Cho	NULL
,	NULL
L.	NULL
Y.	NULL
Lee	NULL
,	NULL
S.	NULL
Kovats	NULL
,	NULL
J.	NULL
Beitz	NULL
,	NULL
J.S	NULL
.	NULL

Blum	NULL
,	NULL
and	NULL
G.T	NULL
.	NULL

Nepom	NULL
.	NULL

1997	NULL
.	NULL

Intestinal	NULL
epithelial	NULL
cells	NULL
utilize	NULL
two	NULL
distinct	NULL
pathways	NULL
for	NULL
HLA	NULL
class	NULL
II	NULL
antigen	NULL
processing	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

100:204-215	NULL
.	NULL

15	NULL
.	NULL

Hirata	NULL
,	NULL
I.	NULL
,	NULL
LL	NULL
.	NULL

Austin	NULL
,	NULL
W.H	NULL
.	NULL

Blackwell	NULL
,	NULL
J.R.	NULL
Weber	NULL
,	NULL
and	NULL
W.O	NULL
.	NULL

Dobbins	NULL
,	NULL
IIL	NULL
.	NULL

1986	NULL
.	NULL

Immunoelectron	NULL
microscopic	NULL
localization	NULL
of	NULL
HLA-DR	NULL
antigen	NULL
in	NULL
control	NULL
small	NULL
intestine	NULL
and	NULL
colon	NULL
and	NULL
in	NULL
inflammatory	NULL
bowel	NULL
disease	NULL
.	NULL

Dig	NULL
.	NULL

Dis	NULL
.	NULL

Sci	NULL
.	NULL

31:1317-1330	NULL
.	NULL

16	NULL
.	NULL

Sarles	NULL
,	NULL
J.	NULL
,	NULL
J.P.	NULL
Gorvel	NULL
,	NULL
D.	NULL
Olive	NULL
,	NULL
S.	NULL
Maroux	NULL
,	NULL
C.	NULL
Mawas	NULL
,	NULL
and	NULL
F.	NULL
Giraud	NULL
.	NULL

1987	NULL
.	NULL

Subcellular	NULL
localization	NULL
of	NULL
class	NULL
I	NULL
(	NULL
A	NULL
,	NULL
B	NULL
,	NULL
C	NULL
)	NULL
and	NULL
class	NULL
II	NULL
(	NULL
DR	NULL
and	NULL
DQ	NULL
)	NULL
MHC	NULL
antigens	NULL
in	NULL
jejunal	NULL
epithelium	NULL
of	NULL
children	NULL
with	NULL
coelic	NULL
disease	NULL
.	NULL

J.	NULL
Pediatr	NULL
.	NULL

Gastroenterol	NULL
.	NULL

Nutr	NULL
.	NULL

6:51-56	NULL
.	NULL

17	NULL
.	NULL

Mayrhofer	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
LD	NULL
.	NULL

Spargo	NULL
.	NULL

1990	NULL
.	NULL

Distribution	NULL
of	NULL
class	NULL
II	NULL
major	NULL
histocompatibility	NULL
antigens	NULL
in	NULL
enterocytes	NULL
of	NULL
the	NULL
rat	NULL
jejunum	NULL
and	NULL
their	NULL
association	NULL
with	NULL
organelles	NULL
of	NULL
the	NULL
endocytic	NULL
pathway	NULL
.	NULL

Immunology	NULL
.	NULL

70:11-19	NULL
.	NULL

18	NULL
.	NULL

Madara	NULL
,	NULL
J.L	NULL
.	NULL

,	NULL
and	NULL
J.	NULL
Stafford	NULL
.	NULL

1989	NULL
.	NULL

Interferon-y	NULL
directly	NULL
affects	NULL
barrier	NULL
function	NULL
of	NULL
cultured	NULL
intestinal	NULL
epithelial	NULL
monolayers	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

83:724-727	NULL
.	NULL

19	NULL
.	NULL

Bradley	NULL
,	NULL
M.B	NULL
.	NULL

,	NULL
J.M	NULL
.	NULL

Fernandez	NULL
,	NULL
G.	NULL
Ungers	NULL
,	NULL
T.	NULL
Diaz-Barrientos	NULL
,	NULL
V.	NULL
Steimle	NULL
,	NULL
B.	NULL
Mach	NULL
,	NULL
R.	NULL
O'Reilly	NULL
,	NULL
and	NULL
J.S	NULL
.	NULL

Lee	NULL
.	NULL

1997	NULL
.	NULL

Correction	NULL
of	NULL
defective	NULL
expression	NULL
in	NULL
MHC	NULL
class	NULL
II	NULL
deficiency	NULL
(	NULL
bare	NULL
lymphocyte	NULL
syndrome	NULL
)	NULL
cells	NULL
by	NULL
retroviral	NULL
transduction	NULL
of	NULL
CHTA	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

159:1086-1095	NULL
.	NULL

20	NULL
.	NULL

Hughson	NULL
,	NULL
E.J	NULL
.	NULL

,	NULL
and	NULL
R.P	NULL
.	NULL

Hirt	NULL
.	NULL

1996	NULL
.	NULL

Assessment	NULL
of	NULL
cell	NULL
polarity	NULL
.	NULL

In	NULL
Epithelial	NULL
Cell	NULL
Culture	NULL
.	NULL

A.J	NULL
.	NULL

Shaw	NULL
,	NULL
editor	NULL
.	NULL

IRL	NULL
Press	NULL
,	NULL
Oxford	NULL
,	NULL
UK	NULL
.	NULL

37-66	NULL
.	NULL

21	NULL
.	NULL

Planchon	NULL
,	NULL
S.M	NULL
.	NULL

,	NULL
CA	NULL
.	NULL

Martins	NULL
,	NULL
RL	NULL
.	NULL

Guerrant	NULL
,	NULL
and	NULL
J.K.	NULL
Roche	NULL
.	NULL

1994	NULL
.	NULL

Regulation	NULL
of	NULL
intestinal	NULL
epithelial	NULL
barrier	NULL
function	NULL
by	NULL
TGF-B	NULL
1	NULL
.	NULL

Evidence	NULL
for	NULL
its	NULL
role	NULL
in	NULL
abrogating	NULL
the	NULL
effect	NULL
of	NULL
a	NULL
T	NULL
cell	NULL
cytokine	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

153:5730-5739	NULL
.	NULL

22	NULL
.	NULL

Woods	NULL
,	NULL
A.	NULL
,	NULL
H.Y	NULL
.	NULL

Chen	NULL
,	NULL
M.E	NULL
.	NULL

Trumbauer	NULL
,	NULL
A.	NULL
Sirotina	NULL
,	NULL
R.	NULL
Cummings	NULL
,	NULL
and	NULL
D.M	NULL
.	NULL

Zaller	NULL
.	NULL

1994	NULL
.	NULL

Human	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
II-restricted	NULL
T	NULL
cell	NULL
responses	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

180:173-181	NULL
.	NULL

23	NULL
.	NULL

Genevée	NULL
,	NULL
C.	NULL
,	NULL
A.	NULL
Diu	NULL
,	NULL
J.	NULL
Nierat	NULL
,	NULL
A.	NULL
Caignard	NULL
,	NULL
P.-Y	NULL
.	NULL

Dietrich	NULL
,	NULL
L.	NULL
Ferra-dini	NULL
,	NULL
S.	NULL
Roman-Roman	NULL
,	NULL
F.	NULL
Triebel	NULL
,	NULL
and	NULL
T.	NULL
Hercend	NULL
.	NULL

1992	NULL
.	NULL

An	NULL
experimentally	NULL
validated	NULL
panel	NULL
of	NULL
subfamily-specific	NULL
oligonucleotide	NULL
primers	NULL
(	NULL
Val-w29/Vb1-w24	NULL
)	NULL
for	NULL
the	NULL
study	NULL
of	NULL
human	NULL
T	NULL
cell	NULL
receptor	NULL
variable	NULL
V	NULL
gene	NULL
segment	NULL
usage	NULL
by	NULL
polymerase	NULL
chain	NULL
reaction	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

22:1261-1269	NULL
.	NULL

24	NULL
.	NULL

Colgan	NULL
,	NULL
S.P	NULL
.	NULL

,	NULL
C.A	NULL
.	NULL

Parkos	NULL
,	NULL
J.B.	NULL
Matthews	NULL
,	NULL
L.	NULL
D'Andrea	NULL
,	NULL
C.S	NULL
.	NULL

Awtrey	NULL
,	NULL
A.H.	NULL
Lichtman	NULL
,	NULL
C.	NULL
Delp-Archer	NULL
,	NULL
and	NULL
J.L	NULL
.	NULL

Madara	NULL
.	NULL

1994	NULL
.	NULL

Interferon-y	NULL
induces	NULL
a	NULL
cell	NULL
surface	NULL
phenotype	NULL
switch	NULL
on	NULL
T84	NULL
intestinal	NULL
epithelial	NULL
cells	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Physiol	NULL
.	NULL

36	NULL
:	NULL
C402-C410	NULL
.	NULL

25	NULL
.	NULL

Gottardi	NULL
,	NULL
C.J	NULL
.	NULL

,	NULL
L.A.	NULL
Dunbar	NULL
,	NULL
and	NULL
M.J.	NULL
Caplan	NULL
.	NULL

1995	NULL
.	NULL

Biotinylation	NULL
and	NULL
assessment	NULL
of	NULL
membrane	NULL
polarity	NULL
:	NULL
caveats	NULL
and	NULL
methodological	NULL
concerns	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Physiol	NULL
.	NULL

268	NULL
:	NULL
F285-F295	NULL
.	NULL

26	NULL
.	NULL

Strohmeier	NULL
,	NULL
G.R	NULL
.	NULL

,	NULL
W.I	NULL
.	NULL

Lencer	NULL
,	NULL
TW	NULL
.	NULL

Patapoff	NULL
,	NULL
LF	NULL
.	NULL

Thompson	NULL
,	NULL
SIL	NULL
.	NULL

Carlson	NULL
,	NULL
S.J	NULL
.	NULL

Moe	NULL
,	NULL
D.K	NULL
.	NULL

Carnes	NULL
,	NULL
R.J.	NULL
Mrsny	NULL
,	NULL
and	NULL
J.L	NULL
.	NULL

Madara	NULL
.	NULL

1997	NULL
.	NULL

Surface	NULL
ex-pression	NULL
,	NULL
polarization	NULL
,	NULL
and	NULL
functional	NULL
significance	NULL
of	NULL
CD73	NULL
in	NULL
human	NULL
intestinal	NULL
epithelia	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

99:2588-2601	NULL
.	NULL

27	NULL
.	NULL

Chang	NULL
,	NULL
C.-H.	NULL
,	NULL
and	NULL
R.A.	NULL
Flavell	NULL
.	NULL

1995	NULL
.	NULL

Class	NULL
II	NULL
transactivator	NULL
regulates	NULL
the	NULL
expression	NULL
of	NULL
multiple	NULL
genes	NULL
involved	NULL
in	NULL
antigen	NULL
presentation	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

181:765-767	NULL
.	NULL

28	NULL
.	NULL

Gottlieb	NULL
,	NULL
T.A	NULL
.	NULL

,	NULL
LE	NULL
.	NULL

Ivanov	NULL
,	NULL
M.	NULL
Adesnik	NULL
,	NULL
and	NULL
D.D	NULL
.	NULL

Sabatini	NULL
.	NULL

1993	NULL
.	NULL

Actin	NULL
microfilaments	NULL
play	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
endocytosis	NULL
at	NULL
the	NULL
apical	NULL
but	NULL
not	NULL
the	NULL
basolateral	NULL
surface	NULL
of	NULL
polarized	NULL
epithelial	NULL
cells	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

120:695-710	NULL
.	NULL

29	NULL
.	NULL

Jackman	NULL
,	NULL
M.R	NULL
.	NULL

,	NULL
W.	NULL
Shurety	NULL
,	NULL
J.A	NULL
.	NULL

Ellis	NULL
,	NULL
and	NULL
J.P.	NULL
Luzio	NULL
.	NULL

1994	NULL
.	NULL

Inhibition	NULL
of	NULL
apical	NULL
but	NULL
not	NULL
basolateral	NULL
endocytosis	NULL
of	NULL
ricin	NULL
and	NULL
folate	NULL
in	NULL
Caco-2	NULL
cells	NULL
by	NULL
cytochalasin	NULL
D.	NULL
J	NULL
.	NULL

Cell	NULL
Sci	NULL
.	NULL

107:2547-2556	NULL
.	NULL

30	NULL
.	NULL

Lencer	NULL
,	NULL
W.1	NULL
.	NULL

,	NULL
G.	NULL
Strohmeier	NULL
,	NULL
S.	NULL
Moe	NULL
,	NULL
S.L	NULL
.	NULL

Carlson	NULL
,	NULL
C.T	NULL
.	NULL

Constable	NULL
,	NULL
and	NULL
J.L	NULL
.	NULL

Madara	NULL
.	NULL

1995	NULL
.	NULL

Signal	NULL
transduction	NULL
by	NULL
cholera	NULL
toxin	NULL
:	NULL
processing	NULL
in	NULL
vesicular	NULL
compartments	NULL
does	NULL
not	NULL
require	NULL
acidification	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Physiol	NULL
.	NULL

269	NULL
:	NULL
G548-GS557	NULL
.	NULL

31	NULL
.	NULL

Pociot	NULL
,	NULL
F.	NULL
,	NULL
A.G.	NULL
Wilson	NULL
,	NULL
J.	NULL
Nerup	NULL
,	NULL
and	NULL
G.	NULL
W.	NULL
Duff	NULL
.	NULL

1993	NULL
.	NULL

No	NULL
independent	NULL
association	NULL
between	NULL
a	NULL
tumor	NULL
necrosis	NULL
factor-	NULL
«	NULL
promoter	NULL
region	NULL
polymorphism	NULL
and	NULL
insulin-dependent	NULL
diabetes	NULL
mellitus	NULL
.	NULL

£ur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

23:3050-3053	NULL
.	NULL

32	NULL
.	NULL

Simonsen	NULL
,	NULL
A.	NULL
,	NULL
E.	NULL
Stang	NULL
,	NULL
B.	NULL
Bremnes	NULL
,	NULL
M.	NULL
Roe	NULL
,	NULL
K.	NULL
Prydz	NULL
,	NULL
and	NULL
O.	NULL
Bakke	NULL
.	NULL

1997	NULL
.	NULL

Sorting	NULL
of	NULL
MHC	NULL
class	NULL
II	NULL
molecules	NULL
and	NULL
the	NULL
associated	NULL
invariant	NULL
chain	NULL
(	NULL
1	NULL
)	NULL
in	NULL
polarized	NULL
MDCK	NULL
cells	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Sci	NULL
.	NULL

110:597-609	NULL
.	NULL

33	NULL
.	NULL

Odorizzi	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
I.S	NULL
.	NULL

Trowbridge	NULL
.	NULL

1997	NULL
.	NULL

Structural	NULL
requirements	NULL
for	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
II	NULL
invariant	NULL
chain	NULL
trafficking	NULL
in	NULL
polarized	NULL
Madin-Darby	NULL
canine	NULL
kidney	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272:11757-11762	NULL
.	NULL

34	NULL
.	NULL

Zhong	NULL
,	NULL
G.	NULL
,	NULL
P.	NULL
Romagnoli	NULL
,	NULL
and	NULL
R.N	NULL
.	NULL

Germain	NULL
.	NULL

1997	NULL
.	NULL

Related	NULL
leucine-based	NULL
cytoplasmic	NULL
targeting	NULL
signals	NULL
in	NULL
invariant	NULL
chain	NULL
and	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
II	NULL
molecules	NULL
control	NULL
endocytic	NULL
presentation	NULL
of	NULL
distinct	NULL
determinants	NULL
in	NULL
a	NULL
single	NULL
protein	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

185:429-438	NULL
.	NULL

35	NULL
.	NULL

Pinet	NULL
,	NULL
V.	NULL
,	NULL
M.	NULL
Vergelli	NULL
,	NULL
R.	NULL
Martin	NULL
,	NULL
O.	NULL
Bakke	NULL
,	NULL
and	NULL
E.O	NULL
.	NULL

Long	NULL
.	NULL

1995	NULL
.	NULL

Antigen	NULL
presentation	NULL
mediated	NULL
by	NULL
recycling	NULL
of	NULL
surface	NULL
HLA-DR	NULL
molecules	NULL
.	NULL

Nature	NULL
.	NULL

375:603-604	NULL
.	NULL

36	NULL
.	NULL

Hunziker	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
C.	NULL
Fumey	NULL
.	NULL

1994	NULL
.	NULL

A	NULL
di-leucine	NULL
motif	NULL
mediates	NULL
endocytosis	NULL
and	NULL
basolateral	NULL
sorting	NULL
of	NULL
macrophage	NULL
IgG	NULL
Fc	NULL
receptors	NULL
in	NULL
MDCK	NULL
cells	NULL
.	NULL

EMBO	NULL
(	NULL
Eur	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

Organ	NULL
.	NULL
)	NULL

J	NULL
.	NULL

13:2963-2969	NULL
.	NULL

37	NULL
.	NULL

Mellman	NULL
,	NULL
I	NULL
.	NULL

1995	NULL
.	NULL

Molecular	NULL
sorting	NULL
of	NULL
membrane	NULL
proteins	NULL
in	NULL
polarized	NULL
and	NULL
nonpolarized	NULL
cells	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
Symp	NULL
.	NULL

Quant	NULL
.	NULL

Biol	NULL
.	NULL

LX:745-752	NULL
.	NULL

38	NULL
.	NULL

Siegrist	NULL
,	NULL
C.A	NULL
.	NULL

,	NULL
E.	NULL
Martinez-Soria	NULL
,	NULL
I.	NULL
Kern	NULL
,	NULL
and	NULL
B.	NULL
Mach	NULL
.	NULL

1995	NULL
.	NULL

A	NULL
novel	NULL
antigen-processing-defective	NULL
phenotype	NULL
in	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
II-positive	NULL
CIITA	NULL
transfectants	NULL
is	NULL
corrected	NULL
by	NULL
interferon-y	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

182:1793-1799	NULL
.	NULL

39	NULL
.	NULL

Knight	NULL
,	NULL
A.	NULL
,	NULL
E.	NULL
Hughson	NULL
,	NULL
C.R	NULL
.	NULL

Hopkins	NULL
,	NULL
and	NULL
D.F	NULL
.	NULL

Cutler	NULL
.	NULL

1995	NULL
.	NULL

Membrane	NULL
protein	NULL
trafficking	NULL
through	NULL
the	NULL
common	NULL
apical	NULL
endosome	NULL
compartment	NULL
of	NULL
polarized	NULL
caco-2	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

Cell	NULL
.	NULL

6597-610	NULL
.	NULL

40	NULL
.	NULL

Odorizzi	NULL
,	NULL
G.	NULL
,	NULL
A.	NULL
Pearse	NULL
,	NULL
D.	NULL
Domingo	NULL
,	NULL
I.S	NULL
.	NULL

Trowbridge	NULL
,	NULL
and	NULL
C.R	NULL
.	NULL

Hop-kins	NULL
.	NULL

1996	NULL
.	NULL

Apical	NULL
and	NULL
basolateral	NULL
endosomes	NULL
of	NULL
MDCK	NULL
cells	NULL
are	NULL
interconnected	NULL
and	NULL
contain	NULL
a	NULL
polarized	NULL
sorting	NULL
mechanism	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

135:139-152	NULL
.	NULL

41	NULL
.	NULL

Momburg	NULL
,	NULL
F.	NULL
,	NULL
S.	NULL
Fuchs	NULL
,	NULL
J.	NULL
Drexler	NULL
,	NULL
R.	NULL
Busch	NULL
,	NULL
M.	NULL
Post	NULL
,	NULL
G.J	NULL
.	NULL

Hammerling	NULL
,	NULL
and	NULL
L.	NULL
Adorini	NULL
.	NULL

1993	NULL
.	NULL

Epitope-specific	NULL
enhancement	NULL
of	NULL
antigen	NULL
presentation	NULL
by	NULL
invariant	NULL
chain	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

178:1453-1458	NULL
.	NULL

42	NULL
.	NULL

Pinet	NULL
,	NULL
V.	NULL
,	NULL
M.S	NULL
.	NULL

Malnati	NULL
,	NULL
and	NULL
E.O	NULL
.	NULL

Long	NULL
.	NULL

1994	NULL
.	NULL

Two	NULL
processing	NULL
pathways	NULL
for	NULL
the	NULL
MHC	NULL
class	NULL
II-restricted	NULL
presentation	NULL
of	NULL
exogenous	NULL
influenza	NULL
virus	NULL
antigen	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

152:4852-4860	NULL
.	NULL

43	NULL
.	NULL

Ceman	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
A.J	NULL
.	NULL

Sant	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
function	NULL
of	NULL
invariant	NULL
chain	NULL
in	NULL
class	NULL
II-restricted	NULL
antigen	NULL
presentation	NULL
.	NULL

Semin	NULL
.	NULL

Immunol	NULL
.	NULL

7:373-387	NULL
.	NULL

44	NULL
.	NULL

Zhang	NULL
,	NULL
Z.	NULL
,	NULL
and	NULL
J.G	NULL
.	NULL

Michael	NULL
.	NULL

1990	NULL
.	NULL

Orally	NULL
inducible	NULL
immune	NULL
unrespon-siveness	NULL
is	NULL
abrogated	NULL
by	NULL
IFN-y	NULL
treatment	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

144:4163-4165	NULL
.	NULL

45	NULL
.	NULL

Kjerrulf	NULL
,	NULL
M.	NULL
,	NULL
D.	NULL
Grdic	NULL
,	NULL
L.	NULL
Ekman	NULL
,	NULL
K.	NULL
Schon	NULL
,	NULL
M.	NULL
Vajdy	NULL
,	NULL
and	NULL
N.Y.	NULL
Lycke	NULL
.	NULL

1997	NULL
.	NULL

Interferon-y	NULL
receptor-deficient	NULL
mice	NULL
exhibit	NULL
impaired	NULL
gut	NULL
mucosal	NULL
immune	NULL
responses	NULL
but	NULL
intact	NULL
oral	NULL
tolerance	NULL
.	NULL

Immunology	NULL
.	NULL

92:60-68	NULL
.	NULL

Polarity	NULL
and	NULL
HLA	NULL
Class	NULL
II	NULL
_	NULL
803	NULL

